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1) Introduction
„To suppose that the eye, with all its inimitable contrivances for adjusting the focus to 
different distances, for admitting different amounts of light, and for the correction of 
spherical and chromatic aberration, could have been formed by natural selection, seems, I 
freely confess, absurd in the highest possible degree. Yet reason tells me, that if numerous 
gradations from a perfect and complex eye to one very imperfect and simple, each grade 
being useful to its possessor, can be shown to exist; if further, the eye does vary ever so 
slightly, and the variations be inherited, which is certainly the case; and if any variation or 
modification in the organ be ever useful to an animal under changing conditions of life, 
then the difficulty of believing that a perfect and complex eye could be formed by natural 
selection, though insuperable by our imagination, can hardly be considered real. How a 
nerve comes to be sensitive to light, hardly concerns us more than how life itself first 
originated; but I may remark that several facts make me suspect that any sensitive nerve 
may be rendered sensitive to light, and likewise to those coarser vibrations of the air which 
produce sound.“
Ѥ Charles Darwin, On The Origin of Species, Chapter Six, "Organs of Extreme Perfection and Complication"
In his book “The Origin of Species“ (1859), Charles Darwin highlighted the eye within the 
group of “organs of extreme perfection and complication” [1]. Through all of his studies he 
found evidence for the evolution of organs and animals but impressed by the complexity 
and perfection of the eye he used it as an example that even unimaginably complex things 
could have been evolved. Today the evolution of the eye is an established and proven 
theory, well investigated, though not concluded.
! The human eye is one of the most complex within the animal kingdom. It is 
composed of different layers, structures and cell types each unique in its morphology  and 
function (Fig. 1). The cornea is the frontal transparent surface of the anterior eye chamber, 
protecting the fluid in this chamber, the lens and the iris. The sclera is the “white surface“ 
protecting the rest of the eyeball. Together, they  form the outer layer of the eye. The 
intermediate layer is composed of the choroid, harboring the blood drainage of the eye, 
and the ciliary  body, where muscles are found which attach to the zonule fibers attaching 
the lens. Contraction and relaxation of these muscles induces shape changes of the lens, 
allowing accommodation, the sharpening of points in different distances. The neuronal 
inner layer is named retina (Fig. 2). Here we find several specialized cell types, enabling 
this part of the eye to detect light (rod and cone photoreceptors), transform it into electric 
signals, process it further via second order neurons (horizontal, bipolar and amacrine cells) 
and transduce it towards the visual cortex of the brain (ganglion cells). Other cell types 
perform regulatory maintenance (retinal pigment epithelial and Müller glia cells) and 
immunogenic tasks (microglia cells).
Figure 1: Schematic drawing of the human eye. Adapted from http://webvision.med.utah.edu/
5Figure 2: Schematic drawing of the vertebrate retina. Adapted from http://webvision.med.utah.edu/
The human retina harbors 92 million rods and 4.6 million cones which are in total almost 
100 million light sensing cells per eye [2]. With an area of 1094 mm2 , the human retina 
features an average density of ∼90 photoreceptors per µm2 peaking in a special region of 
the primate retina, the fovea, with ∼170 cones / µm2, whereas the rod density was reported 
to be ∼80 - 100 rods / µm2 (see http://webvision.med.utah.edu/). These highly sensitive rod 
photoreceptor cells, which contain the visual pigment rhodopsin, are responsible for 
monochromatic vision under dim light conditions. In contrast, cone photoreceptor cells, 
which contain S-, M-, or L-opsins enable trichromatic vision under normal daylight 
conditions ([3] and Tab. 1). Both photoreceptors feature an outer segment (OS) where the 
light is detected by the visual pigments, localized in repetitive membrane staples (Fig. 3). 
The OSs are directed towards the retinal pigment epithelial (RPE) cell layer (Fig. 2). The 
connecting cilium (CC) is the link between the OS and the inner segment (IS), containing 
the majority  of the mitochondria (mt) of the cell (Fig. 3). Towards the inner retina, a cell 
membrane tunnel connects the IS with the main cell body, containing the nucleus (nuc). In 
rods, the nucleus displays a characteristic condensed chromatin structure whereas in 
cones several condensed spots of heterochromatin can be observed [4]. Additionally, cone 
nuclei could be found predominantly in the outer part of the outer nuclear layer (ONL) as 
indicated in Fig. 3. After detection of light in the OS, an electric current is triggered which is 
transduced via the IS and the nucleus towards the axonal terminal (AT) which projects into 
the outer limiting membrane (OLM) (Fig. 3). There, the signal is picked up  by bipolar and 
horizontal cells, processed and transduced further via retinal ganglion cells (RGCs) 
towards the brain. A small sub-population of RGCs, the so called intrinsically 
photosensitive RGCs (ipRGCs), represent, next to rods and cones, a third population of 
light-detecting mammalian retinal neurons. While rods and cones react on short timescales 
within milliseconds, ipRGCs seem to be responsible for light-sensing actions on longer 
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timescales, like synchronization of circadian rhythms, modulation of melatonin release and 
regulation of pupil size [5,6].
Photoreceptors are of prime importance for humans, since vision is one of the most 
important senses for us. In our daily  life, where nearly every action is dependent on visual 
input, an impairment or a loss of eyesight leads to severe disability.
! With a non-syndromic prevalence of 1:4000, retinitis pigmentosa (RP), a collective 
term for a group of inherited retinal eye diseases, represents, together with age-related 
macula degeneration (AMD), one of the main causes for visual impairment and blindness 
in industrialized countries [7]. The dominant reason for vision loss is, in both cases, the 
irreversible loss of photoreceptor cells located in the ONL of the retina. To date, no 
effective treatment is available to preserve or regain visual function in affected patients.
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Figure 3 (left): Schematic drawing of a rod and cone 
photoreceptor cell. Incoming light is detected at the outer 
segments (OS) of cone and rod photoreceptor cells. The signal is 
translated into an electric current which is transduced further via 
the connecting cilium (CC) and the inner segment (IS), which 
harbors most of the mitochondria (mt) of the cell. Subsequently, 
the signal is transduced via an axon, the cell body which 
contains the nucleus and towards the axonal terminal (AT) where 
it is picked up by bipolar and horizontal cells.
Table 1: Features of light-sensitive cell types in the human 
and mouse retina. Within the mammalian retina, 3 different 
light-sensing cell types could be found, rods, cones and 
intrinsically photosensitive retinal ganglion cells (ipRGCs). They 
are characterized by different visual pigment proteins which 
results in different absorbance spectra, enabling humans to have 
trichromatic vision while mice have only dichromatic vision [3,6].
rod
cone
OLM
ONL
OPL
! Recent promising strategies for new retinal therapeutical approaches focus on one 
hand on the development of gene therapies, where an artificially  introduced wt allele 
compensates a mutated gene, and on the other hand on cell therapies, where stem or 
photoreceptor precursor cells (PPCs) are transplanted to the sub-retinal space to replace 
degenerated host photoreceptors (Fig. 4). In comparison to ocular cell therapies, viral 
vector-mediated gene therapies for retinal degenerative diseases are relatively well 
investigated and some are already in clinical trial phases [8-10]. But their specificity  limit 
their effectiveness to the level of mutations of single genes. Therefore, only subgroups of 
patients with retinal degenerative disorders may benefit from them. In contrast, the cell 
transplantational approach is still in its infancy. Nevertheless, a cell therapy implies a 
remarkable advantage. Retinal degenerative diseases with common phenotype, but a 
variety of genes that might be mutated, may be cured by introducing new, genetically 
native and healthy PPCs.
Lens
RPE
Retina
cells / viral vectors
Figure 4: Schematic drawing of the principle of a sub-retinal injection. With sub-retinal injections, cells 
(for cell therapy) or viral vectors (for gene therapy) are delivered to the region between photoreceptor outer 
nuclear layer (ONL, the outermost region of the retina) and the retinal pigment epithelial cell layer (RPE) of a 
host animal. The injection needle is inserted through a small hole between sclera and cornea, navigated 
under visual control through the vitreus by avoiding the lens and placed behind the retina.
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! This study, which is subdivided into three parts, addresses the issue of non-
reversible photoreceptor cell loss due to retinal degenerative diseases by investigating in 
the first two parts new qualitative as well as quantitative approaches in the field of retinal 
cell therapy. In the third part an ocular gene therapeutical approach targeting prominin-1, a 
gene involved in retinal degenerative disorders, was investigated.
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2) Cell therapy: Increased integration of transplanted 
CD73-positive photoreceptor precursors into adult 
mouse retina
2.1) Introduction
Following up  on initial studies by Peter Gouras et al. [11-13] already two decades ago, 
several recent reports demonstrated that transplantation of photoreceptor precursor cells 
(PPCs) into the sub-retinal space of adult mice results in integration into the host outer 
nuclear layer (ONL) and formation of mature rod and cone photoreceptors [14-17]. 
Importantly, donor cells correctly integrated and developed outer segments (OSs) located 
in the sub-retinal space and axonal terminals placed in the outer plexiform layer (OPL) in 
close proximity to endogenous bipolar cells, indispensable prerequisites for a functional 
connection to the host neural circuitry. Indeed, first studies suggested functionality of 
donor-derived photoreceptors as demonstrated by extracellular field potential recordings 
from the ganglion cell layer and pupillary reflexes [15], electro-retinography measurements 
[18] as well as patch-clamp  recordings, optokinetic tracking, water-maze, and optical 
imaging from the visual cortex [19].
! To date, several studies used heterogeneous cell suspensions generated by 
dissociation of entire retinae. Previous data indicate that cell suspensions from mouse 
retinae isolated between postnatal day (PN) 3 - 5 have the highest potential for integration 
[15,16]. Consistent for all published studies in which primary retinal cells were used for 
transplantation is the relatively  low number of donor-derived photoreceptors that integrated 
into the ONL of the host. Various approaches have been performed to increase the 
number and survival of integrating photoreceptors including disruption of the outer limiting 
membrane [20,21], immune suppression [22], anti-apoptotic treatment of donor cells [23], 
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double-injection per eye, pre-detachment, scleral puncture [19] or enrichment of 
fluorescence reporter expressing donor cells by flow cytometry [17].
! However, purification of transplantable cells based on the expression of reporter 
genes might not be an approach that can be used in possible future therapeutic 
applications in humans. Instead, it would be favorable to purify donor cells by  cell-type 
specific cell surface markers. Such selection and enrichment methods will be specifically 
important when photoreceptor precursors are generated from an in vitro expandable cell 
source like pluripotent embryonic stem (ES) or induced pluripotent stem (iPS) cells. 
Current protocols allow the in vitro generation of rod and cone photoreceptors from mouse 
and human pluripotent stem cells albeit still in relative small quantities [18,24-27].
! In this part, I show that ecto-5’-nucleotidase, a 70-kDa glycosyl-phosphatidylinositol 
(GPI)-anchored cell surface molecule, also called cluster of differentiation (CD) 73, is 
highly expressed in young rod photoreceptors confirming recent findings [28,29]. 
Furthermore, I demonstrate that magnetic-associated cell sorting (MACS) using antibodies 
against a cell surface antigen, i.e. CD73, is a reliable method for the enrichment of cells of 
the photoreceptor lineage. Importantly, upon transplantation purified suspensions of 
photoreceptor precursors showed a significantly increased integration rate into the ONL of 
adult mice when compared to unsorted or negative sorted cell fractions.
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2.2) Results
2.2.1) Increased expression of CD73 in rod photoreceptors
Recent studies demonstrated that cell suspensions isolated from the mouse retina at post-
natal day 3 to 5 have the highest integration rate after transplantation into the adult mouse 
retina [15-17]. Therefore, murine retinas used in this study for isolation of photoreceptors 
were dissected at PN4. To identify genes that are specifically up-regulated in young rod 
photoreceptors, microarray  analysis was performed by Kai Postel to compare gene 
expression of rhoEGFP-positive and -negative cells isolated from PN4 mice. To further 
specify the profile of rhoEGFP-positive photoreceptors their gene expression was 
additionally compared to nestin-EGFP-positive cells isolated at PN0. Nestin, an 
intermediate filament protein, is highly expressed during retinal development and marks 
retinal progenitor cells. Microarray analysis revealed 8354 significantly  changed entities 
(ANOVA; P = 0.05); 1125 entities showed more than a two-fold higher expression in 
rhoEGFP-positive cells in comparison to rhoEGFP-negative sorted cells (Fig. 5A) and 
nestin-EGFP-positive sorted cells (Fig. 5B). These 1125 entities represent 744 genes. The 
microarray data generated in this study have been published [30] and deposited in the 
National Center for Biotechnology Information’s Gene Expression Omnibus (Bethesda, 
MD, [31]) and are accessible through GEO Series accession number GSE29318 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29318).
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Figure 5: Comparison of the global expression profile of rhoEGFP positive cells versus rhoEGFP 
negative and nestin-EGFP positive cells. Scatter-plots of differentially expressed genes in PN4 rhoEGFP 
positive cells versus PN0 nestin-EGFP positive cells (A) and PN4 rhoEGFP positive versus PN4 rhoEGFP 
negative cells (B) revealed 2-fold gene expression differences (green lines) of 1125 up-regulated and 1948 
down-regulated entities. CD73 is indicated by a green spot (A, B). Adapted from Eberle et al., 2011.
! Several genes specific for the rod photoreceptor lineage — rhodopsin, Pde6b  
(phosphodiesterase subunit 6b), Gngt1 (guanine nucleotide binding protein (G protein) 
gamma transducing activity  polypeptide 1), or recoverin — showed a more than 10-fold 
higher expression in rhoEGFP-positive cells, indicating the high selectivity of FACS 
enrichment for rod photoreceptors (Tab. 3). Microarray analysis also revealed genes 
encoding proteins located on the cell surface that may serve as antigens for antibody-
mediated MACS. For example, CD73 (Nt5e, ecto- 5’-nucleotidase), Cnga1 (cyclic 
nucleotide gated channel alpha 1), Gje1 (gap  junction protein, epsilon 3), and Pcdh15 
(protocadherin 15) showed more than twofold higher expression in rhoEGFP PN4-positive 
cells compared with the other fractions (Fig. 5, Tab. 3). Altogether, 120 entities 
representing 79 different transcriptional units with GO-Term plasma membrane were 
identified and showed a more than twofold higher expression in PN4 rhoEGFP-sorted cells 
([30] Supplementary Table S1, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.
11-7399/-/DCSupplemental).
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Gene Symbol Gene Title GO(Avadis) Fold Change*
Photoreceptor Marker
Rho Rhodopsin Photoreceptor activity +++
Gngt1 Guanine nucleotide binding protein (G
  protein), gamma transducing activity
  polypeptide 1
Signal transducer 
activity
+++
Pde6b Phosphodiesterase 6B, cGMP, rod
  receptor, beta polypeptide
3',5'-cyclic-GMP 
phosphodiesterase 
activity
++
Pde6g Phosphodiesterase 6G, cGMP-specific,
  rod, gamma
cGMP binding ++
Rcvrn Recoverin Calcium ion binding ++
Cell Surface Marker
Cnga1 Cyclic nucleotide gated channel alpha 1 cGMP binding +++
Gje1 Gap junction protein, epsilon 1 Cell morphogenesis ++
Pcdh15 Protocadherin 15 Protein binding +
Nt5e (CD73) 5' nucleotidase, ecto Metal ion binding +
* + 2-10 fold, ++ 10-20 fold, +++ ≥20 fold up-regulated respectively
Table 3: A subset of Genes with Higher Expression in PN4 rhoEGFP-Positive Cells in Comparison to 
PN4 rhoEGFP-Negative and PN0 Nestin-EGFP-Positive Cells. Adapted from Eberle et al., 2011.
! Since the CD73 antibody was commercially available, we further focused on it in 
this study. Indeed, RT-PCR analysis perfomed by Sandra Schubert confirmed the 
expression of CD73 transcripts in PN4 mouse retina (Fig. 6C) and immunocytochemistry, 
using CD73-specific antibodies on dissociated and cultured rhoEGFP retinas showed 
CD73-immunoreactivity in the majority of GFP-positive rod photoreceptors ([30] 
Supplementary Fig. S1, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-7399/-/ 
DCSupplemental). In line with our results, CD73 was recently identified as the first cell 
surface marker for early stages of the photoreceptor lineage after screening of several CD 
antigens [28]. Because of these findings we evaluated CD73 as the first candidate for 
proof-of-principle experiments investigating the transplantation of cell surface marker–
enriched photoreceptors.
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Figure 6: Analysis of unsorted, CD73-negative, and CD73-positive cells isolated from PN4 mouse 
retinas on MACS procedures. APC-conjugated secondary antibodies were used to detect CD73-positive 
cells after MACS. Unsorted cell fractions contained 52.0% ± 9.89% CD73-positive cells (Ai, B). After MACS, 
the number of CD73-positive cells was reduced to 16.0% ± 10.76% in CD73-negative sorted fractions (Aii, B) 
and increased to 83.0% ± 4.04% in positive sorted fractions (Aiii, B). Semiquantitative RT-PCR analysis 
using CD73-specific primers revealed CD73 expression in the PN4 mouse retina and CD73-positive cells 
(C). Using rhodopsin-specific primers, a strong expression of this rod photoreceptor marker was also 
detected in CD73-positive cells. Actin was used as internal control. Weak CD73 expression was also 
detected in the thymus (positive control), whereas lung and muscle served as negative controls beside 
thymus preparations without reverse transcriptase (− RT-thymus). Quantification of propidium iodide 
incorporation in PN4 retinal cells from rhoEGFP retinas after CD73 MACS or GFP FACS (D). In MACS 
propagated cells (MACS− and MACS+) an average of 15% showed incorporation of propidium iodide (PI), 
representing dead cells. The number of PI-positive cells was significantly increased in cells after flow 
cytometry (~37%; FACS− and FACS+). In comparing PI incorporation of unsorted cells after 60 or 180 
minutes, similar proportions of PI-positive cells were detected (unsorted 60 minutes: 15% and unsorted 180 
minutes: 37%). *P < 0.05, **P < 0.01, ***P < 0.001. Adapted from Eberle et al., 2011.
15
2.2.2) MACS enrichment of photoreceptor precursors
We further investigated whether CD73 antibodies are reliable tools for purification of cells 
of the photoreceptor lineage. Neural retina-specific leucine zipper (Nrl) is a transcription 
factor of the Maf subfamily and a critical regulator in photoreceptor final differentiation, 
expressed after cell cycle exit [32]. Without Nrl, the retina is devoid of rods, because all rod 
precursors transform into cone-like cells [32]. Therefore, Nrl is crucial for the differentiation 
of PPCs towards the rod lineage. In contrast, Cone-rod homeobox (Crx), another 
photoreceptor-specific transcription factor expressed earlier in development than Nrl and in 
rods and cones, is widely used as a marker for immature, post-mitotic photoreceptors. In 
this study, Nrl-EGFP and rhoEGFP transgenic mice are used as reporter to identify young 
rod photoreceptors in the retina.
! In unsorted, CD73-MACS-negative, or CD73-MACS-positive cell fractions the 
number of EGFP-positive rod photoreceptors was analyzed by Sandra Schubert using flow 
cytometry and fluorescence microscopy after in vitro culturing. To test whether CD73-
based MACS indeed results in enrichment of CD73-positive cells, Sandra Schubert first 
analyzed the number of CD73-positive cells in unsorted, CD73-negative and -positive 
sorted fractions by flow cytometry  with APC-conjugated secondary antibodies. The results 
showed that unsorted cells contained 52% ± 9.89% CD73-positive cells (Figs. 6Ai, 6B) 
whereas negative fractions contained only 16% ± 10.76% (Figs. 6Aii, 6B). As anticipated, a 
strong increase—that is, 83% ± 4.04%, of CD73-positive cells was detected in the CD73-
positive MAC- sorted fractions, confirming their successful enrichment by  MACS (Figs. 
6Aiii, 6B). Semiquantitative RT-PCR revealed also a strong expression of CD73 transcripts 
in CD73-positive sorted cells, whereas unsorted fractions and CD73-negative fractions 
showed moderate or low expression, respectively  (Fig. 6C). Interestingly, RT-PCR analysis 
using rhodopsin-specific primers revealed a high expression of rhodopsin transcripts in 
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CD73- positive sorted fractions in contrast to CD73-negative ones, demonstrating the 
enrichment of rod photoreceptors (Fig. 6C).
! The most common techniques for the enrichment of specific cell-types from 
heterogenous cell populations are either MACS or flow cytometry. In our hands, CD73-
based MACS of retinas from one litter (6–10 pups) typically  resulted in 20 to 30 million 
rhoEGFP-positive cells in ~60 minutes. In contrast, 4.4 to 7 million rhoEGFP-positive cells 
were isolated by flow cytometry with green fluorescence in ~180 minutes. To evaluate why 
MACS resulted in a higher number of cells, Sandra Schubert compared the effect of both 
techniques on the survival of the photoreceptor precursors. The number of dead cells was 
quantified by propidium iodide incorporation followed by flow cytometry. Whereas MAC-
sorted cell fractions contained an average of 15% propidium iodide–positive cells, their 
number increased up to ~37% in the FAC-sorted fractions (Fig. 6D). Given that the time for 
high yield enrichment by  flow cytometry was considerably  longer, Sandra Schubert 
investigated whether the prolonged periods in suspension, rather than the sorting method 
itself, might be the underlying cause of the reduced number of cells obtained by FACS. 
Indeed, the analysis of unsorted cell suspensions 60 or 180 minutes after tissue 
dissociation revealed similar amounts of propidium iodide–positive cells (Fig. 6D). Thus, 
the increased cell death observed on flow cytometry appears to be due to the prolonged 
incubation periods, rather than the procedure itself. Consequently, all further experiments 
were performed with the fast and easy method, MACS.
! By using retinas from Nrl-EGFP and rhoEGFP mice, Sandra Schubert next 
quantitatively investigated the enrichment of cells of the rod photoreceptor lineage by 
means of CD73-based MACS. FACS quantification showed that unsorted cell fractions 
contained 53% ± 5.25% Nrl-EGFP-positive (Figs. 7Ai, 7B) and 41% ±  3.35% rhoEGFP-
positive (Figs. 7Ci, 7D) cells. In contrast, the CD73-positive cell fractions showed a 
significantly increased number of Nrl-EGFP- and rhoEGFP-positive cells, to 87% ± 6.33% 
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(Figs. 7Aiii, 7B) and 74% ± 9.95% (Figs. 7Ciii, 7D), respectively. Furthermore, in CD73-
negative cell fractions the amount of Nrl-EGFP- and rhoEGFP-positive cells was strongly 
reduced (25.0% ± 2.96%; Figs. 7Aii, 7B; 6.0% ±  2.3%; Figs. 7Cii, 7D, respectively). In 
addition to the quantification of Nrl-EGFP- and rhoEGFP-positive cells from freshly isolated 
cells, the three separated cell fractions were further cultivated by Sandra Schubert in vitro 
for either 4 hours or 4 days. Immunocytochemistry  on cultured cell fractions from 
rhoEGFP retinas after 4 days revealed a large number of CD73 - immuno-reactivity  events 
in positive sorted cells, whereas their number in negative fractions was substantially 
reduced ([30] Supplementary Fig. S1, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.
11-7399/-/DCSupplemental). Importantly, virtually all GFP-positive cells (rod 
photoreceptors) showed CD73 - immuno-reactivity, irrespective of the cell fraction 
analyzed ([30] Supplementary Fig. S1, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.
11-7399/-/DCSupplemental). Quantification of in vitro propagated cell fractions showed 
also a significant increase in the number of Nrl-EGFP- and rhoEGFP-positive cells in the 
CD73-positive fractions by comparison to unsorted or negative ones (Fig. 7; [30] 
Supplementary Fig. S2, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-7399/-/
DCSupplemental): 4 hours after MACS, the CD73-positive fractions contained 62.0% ± 
4.56% Nrl-EGFP- positive (Fig. 7Ei) or 66.0% ± 3.42% rhoEGFP-positive (Fig. 7Fi) cells in 
comparison to unsorted cells (Nrl-EGFP, 23.0% ±  2.62%; rhoEGFP, 18% ± 0.99%) or 
CD73-negative cells (Nrl-EGFP, 2.0% ± 0.41%; rhoEGFP, 4.0% ±  1.21%; Figs. 7Ei, 7Fi). 
After 4 days in culture, similar proportions of EGFP-positive cells were detected for 
unsorted (Nrl-EGFP, 19.0% ± 0.62%; rhoEGFP, 10.0% ±  0.41%), negative (Nrl-EGFP, 
2.0% ±  0.28%; rhoEGFP, 1.0% ±  0.34%), and positive (Nrl-EGFP, 53.0% ± 9.01%; 
rhoEGFP, 63.0% ± 2.71%) fractions (Figs. 7Eii, 7Fii), although with a slight decrease in all 
fractions in comparison to the 4-hour culturing time. Taken together, we could demonstrate 
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by using two independent EGFP-reporter lines that CD73 is a useful marker for enriching 
rod photoreceptor precursors via MACS.
Figure 7: Analysis of unsorted, CD73-negative, and CD73-positive cells isolated from PN4 retinas 
after MACS. Quantification of dissociated retinal tissue from Nrl-EGFP mice by flow cytometry, directly after 
CD73-based MACS revealed a significant increase in GFP-positive cells in CD73-positive fractions (Aiii, B, 
CD73+) in comparison to unsorted cell fractions (Ai, B), whereas the number of GFP-positive cells 
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significantly decreased in CD73-negative fractions (Aii, B, CD73–). Similar results were obtained after 
quantification of cells isolated from rhoEGFP transgenic retinas (C, D). Note the higher number of GFP-
negative cells in CD73-positive fractions sorted from rhoEGFP (Ciii) in comparison to Nrl-EGFP (Aiii) retinas. 
The number of GFP-positive cells was additionally quantified after in vitro culturing of CD73-sorted fractions 
on coverslips for 4 hours (Ei, Fi) or 4 days (Eii, Fii). CD73-positive fractions contained significantly higher 
amounts of GFP-positive cells in comparison to unsorted fractions from Nrl-EGFP (E) and rhoEGFP (F) 
transgenic retinas, whereas CD73-negative cells contained a significantly reduced number of GFP-positive 
cells (E, F) at both time points. n, number of experiments. *P < 0.05, **P < 0.01, ***P < 0.001. Adapted from 
Eberle et al., 2011.
2.2.3) Transplantation of enriched photoreceptor precursors
Promoter-driven expression of fluorescence reporters (as in Nrl-EGFP mice) results in 
cytoplasmic located reporter protein and strong labeling of the cell body of photoreceptors, 
including axonal terminals and inner segments. However, OS are only faintly stained in 
such reporter mice, and thus detailed analysis of OS formation of donor cells in high 
resolution is difficult to perform [16]. The fusion of EGFP to rhodopsin in rhoEGFP mice, in 
contrast, allows the detection and investigation of OS in more detail, as rhodopsin and 
thus EGFP are exclusively located in the OS disc membranes in mature photoreceptors 
[33]. Consequently, the cell body in mature photoreceptors of rhoEGFP mice are not 
labeled by the reporter (Fig. 8B). Thus, for all transplantation experiments, donor cells 
were isolated from rhoEGFP mice that additionally carried a ubiquitously expressed actin-
DsRed transgene (Fig. 8) allowing simultaneous identification of integrated donor cells and 
formation of OS. Although the DsRed transgene was virtually expressed in all retinal cell 
types, the fluorescence signal intensity was highly variable. Of note, before the formation 
of OS during development (Fig. 8A) or after dissociation (Fig. 8C) young photoreceptors of 
rhoEGFP mice show EGFP expression located in the entire cell as could be also shown by 
immunocytochemistry using rhodopsin-specific antibodies ([30] Supplementary Figs. S3A–
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C, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-7399/-/DCSupplemental). In addi- 
tion, all GFP-positive cells from rhoEGFP retinas expressed recoverin, another 
photoreceptor marker ([30] Supplementary Figs. S3D–F, http://www.iovs.org/lookup/suppl/
doi: 10.1167/iovs.11-7399/-/DCSupplemental).
Figure 8: Reporter expression in rhoEGFP/DsRed double transgenic mice. Section of a rhoEGFP/
DsRed retina at PN4 (A). All retinal cells show red fluorescence due to expression of DsRed albeit in 
different intensities. In the forming ONL, most of the cells show strong EGFP expression. Photoreceptors 
have not generated OS at this developmental stage and express the rhodopsin-EGFP fusion protein in the 
entire cell. After maturation (a retinal section at PN29 is shown) rhodopsin expression and thus EGFP-
positivity is restricted to the OS of photoreceptors whereas red fluorescence can be detected in all retinal cell 
types, including endothelial cells albeit in highly variable intensities (B). Cells of a dissociated PN4 rhoEGFP/ 
DsRed retina after 4 days in culture. All cells show red fluorescence (DsRed), whereas many additionally 
express EGFP indicating them as rod photoreceptors (C). GCL, ganglion cell layer; INL, inner nuclear layer; 
IPL, inner plexiform layer; NB, neuroblast layer; ONL, outer nuclear layer; OS, outer segment. Scale bar: (A, 
B) 50 µm; (C) 20 µm. Adapted from Eberle et al., 2011.
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! After CD73-based MACS unsorted, negative and positive cell fractions were 
transplanted into the sub-retinal space of adult wild-type mice. Three weeks after 
transplantation, experimental retinas were analyzed for the integration of donor cells by 
fluorescence microscopy. Several DsRed-positive donor cells were found correctly 
integrated into the ONL of host retinas resembling the morphology of mature 
photoreceptors: a round, condensed nucleus containing a cell body located in the ONL, a 
synaptic terminal placed in the OPL, and an inner segment above the ONL (Figs. 9A–D). 
Furthermore, several integrated donor cells generated an EGFP-positive OS (Figs. 9A–D). 
Besides showing the characteristic morphology of mature photoreceptors and expression 
of rhodopsin-fused EGFP, all integrated donor cells expressed recoverin (data not shown; 
see also [16]). Quantification of integrated donor photoreceptors revealed a significantly 
higher integration rate of cells from the CD73-positive sorted fractions in comparison to 
negative or unsorted fractions. Whereas transplantation of unsorted or CD73-negative 
cells resulted in integration of 680 ± 410 cells/retina or 144 ± 102 cells/retina, respectively, 
CD73-positive cells showed an integration rate of 2199 ±  1006 cells/retina (Fig. 9E). Thus, 
the number of donor-derived photoreceptors that integrated into the ONL of adult hosts 
was increased by approximately threefold. We also found few integrated rhoEGFP-positive 
cells after transplantation of CD73-negative fractions. Beside some cells that may have 
escaped the sorting process, these cells may have been also originated from early 
photoreceptor precursors that had not developed further than the Crx or Nrl state and thus 
were CD73-negative when sorted (see the Discussion section).
! Summing up, these data demonstrates, that MACS based on CD73 antibodies is a 
reliable method for the enrichment of transplantable photoreceptors resulting in an 
increased number of donor photoreceptors that successfully integrate into the adult mouse 
retina.
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Figure 9: Integration of MACS-isolated donor cells into adult retinas. The integration potential of 
unsorted, CD73-negative, and CD73-positive retinal cells isolated from rhoEGFP/DsRed mice at PN4 was 
analyzed after transplantation into the sub-retinal space of adult wild-type mice. Donor cells identified by their 
expression of DsRed integrated into the ONL of hosts and developed the typical morphology of mature 
photoreceptors, including a round cell body (D, CB) located in the ONL, an axonal terminal (D, AT) in the 
OPL, and an inner segment (IS) above the ONL. In addition, most donor cells generated an OS identified by 
the distinct expression of GFP at the tip  of the donor photoreceptors (A–C; a magnification of a donor 
photoreceptor is shown in D). Whereas the integration rate of CD73-negative cells was low (144 ± 102 cells/
retina; B, E), many cells from unsorted fractions were found in the ONL (680 ± 410 cells/retina; A, E). 
Transplantation of CD73-positive cell fractions significantly increased the number of integrated donor 
photoreceptors (2199 ± 1006 cells/retina; C, E). AT, axonal terminal; CB, cell body; INL, inner nuclear layer; 
IS, inner segment; OPL, outer plexiform layer; ONL, outer nuclear layer; OS, outer segment. *P < 0.05, **P < 
0.01. Scale bar: (A–C) 50 µm; in (D) 10 µm. Adapted from Eberle et al., 2011.
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2.3) Discussion
To date, there is no treatment available to regain visual function after degeneration of 
photoreceptor cells besides approaches using artificial retinal protheses [34]. Recent 
advantages in cell transplantation strategies for the replacement of photoreceptors in 
inherited forms of retinal degeneration have encouraged further research to pave the way 
toward clinical applications [15-17]. These preclinical studies provide evidence that pre-
differentiated photoreceptors rather than stem and/or progenitor cells resemble a suitable 
cell type that has the potential to integrate into the adult mammalian retina and generate 
mature photoreceptors. Interestingly, initial data imply that donor-derived photoreceptors 
form functional connections to the endogenous neural circuitry [15,18]. One of the 
problems that limit a possible therapeutic use in patients is the low integration rate of 
transplanted cells into the ONL of hosts. Some improvements for donor cell integration 
were recently  shown including short time disruption of the outer limiting membrane [20,21] 
and transplantation of purified cell suspensions enriched for photoreceptor precursors [17]. 
However, photoreceptor enrichment in the latter study was achieved by flow cytometry 
using reporter mice expressing GFP under control of the Crx promoter. Such genetic 
manipulation of cells before transplantation might impede their use in clinical applications.
! In this study, we showed that cells within the rod photoreceptor lineage can be 
efficiently purified by  MACS with antibodies against the cell surface molecule CD73. 
Enriched CD73- positive cell fractions contained ~87% rod photoreceptors (i.e., Nrl-EGFP-
positive cells), an increase of approximately  40% the amount found in unsorted fractions. 
Indeed, microarray analysis demonstrated a more than threefold up-regulation of CD73 
transcripts in rod photoreceptors in comparison to other retinal cells including retinal 
progenitors. These data confirm the recent findings [28] that CD73 is a reliable marker for 
photoreceptors in the mouse retina. Of note, CD73 is also a marker of rod photoreceptors 
in primates, as demonstrated in FACS-purified cells from the common marmoset retina 
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[28] implying that CD73 is a promising candidate for the enrichment of rods from human 
cell sources.
! Notably, CD73-enriched cell fractions showed a significantly increased integration 
potential in comparison to unsorted cells after transplantation into adult mouse retinas. 
This finding demonstrates that purification of the proper cell type before transplantation is 
highly important and that young photoreceptors rather than retinal progenitors, which are 
mainly  contained in the CD73-negative fractions, have the potential to integrate into the 
ONL. For transplantation, I used photoreceptors from double reporter mice that express 
DsRed ubiquitously as well as rhodopsin-EGFP fusion protein located on mature 
photoreceptor OSs, resulting in the identification of integrated donor cells without further 
staining procedures. Furthermore, rhodopsin-fused EGFP allows, for the first time, direct 
identification of fully mature photoreceptors and the detailed analysis of OS formation 
down to the ultrastructural level in wild-type mice, as well as mouse models of retinal 
degeneration after transplantation (see this work, section 3).
! Technically, the use of cell surface antigens for the purification of young 
photoreceptors allows the separation of target cells by  MACS. Compared to flow 
cytometry, the former method has the advantage that much more cells can be purified in a 
shorter period leading to increased photoreceptor survival. Indeed, I demonstrate here that 
the time-consuming sorting procedure to enrich a high number of photoreceptor precursors 
(e.g., by flow cytometry), results in increased cell damage and eventually  death, which 
obviously negatively  affects the survival rate of photoreceptor donor cells after 
transplantation [25]. However, flow cytometry has numerous advantages, including 
enrichment with highest purity  and the possibility of separating cells by using multiple 
markers simultaneously. This process may also be necessary for optimizing sorts when 
specific sub-populations and/or additional combination with vital dyes are needed. 
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Therefore, reducing the procedure time may result at the end in an increase of integration 
rate as recently suggested [17].
! In our hands, MACS resulted in an average enrichment of rod photoreceptors (Nrl-
EGFP-positive cells) to 87% in CD73-positive fractions. Possibly the enrichment of rod 
photoreceptors by CD73 (the maximum in this study was 92.5% rods) can be further 
increased, for example, by optimizing the procedure, by direct coupling of paramagnetic 
micro-beads to the primary antibody, multiple sortings, prior negative sorting with cell 
surface antigens not expressed in photoreceptors, or controlling flow-through rates by the 
use of automated systems. There was no significant difference between the number of 
CD73-positive and Nrl-EGFP-positive cells in unsorted or CD73-positive fractions. Thus, 
rod photoreceptors represent the major CD73 expressing cell population in the retina. 
Furthermore, the number of rhoEGFP-positive cells was slightly  but significantly  reduced 
to Nrl-EGFP-positive cells in unsorted and CD73-positive cell fractions. In line with these 
findings, the number of rhoEGFP-negative cells was significantly higher than the Nrl-
EGFP-negative cells in CD73-positive fractions. During photoreceptor development, Nrl 
precedes rhodopsin expression, and consequently our findings suggest that CD73 
expression parallels that of Nrl and occurs before that of rhodopsin. Many of the rhoEGFP-
negative cells in CD73-positive sorted cells may represent photoreceptor precursors at an 
earlier developmental stage that already express Nrl, but not rhodopsin. These results are 
in line with the hypothesis that the CD73 expression is downstream of Crx, upstream or 
parallel to Nrl, and upstream of rhodopsin in the developmental hierarchy of 
photoreceptors [28].
! The purification of transplantable photoreceptors is of specific interest in light of 
recent advances in the generation of photoreceptors from pluripotent stem cell sources like 
ES or iPS cells [18,24-27]. Although very promising, the proportion of cells of the 
photoreceptor lineage generated from such cultures is still relatively low, thus requiring 
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effective sorting procedures before transplantation. Easy and fast separation methods like 
MACS, based on cell surface antigens, may be useful tools in this respect. However, the 
use of antibodies against solely CD73 may not represent the optimal sorting strategy since 
this antigen is not restricted to photoreceptors but could also be detected in other cell 
types—for example, T- and B-cell subsets and endothelial cells of capillaries and venules 
[35,36]. This wider expression profile may somehow impair the specific CD73 enrichment 
of photoreceptors from heterogenous cell cultures like those differentiating from pluripotent 
stem cells. Furthermore, during photoreceptor development CD73 expression follows up-
regulation of Crx and then stays stable until photoreceptor maturation [28]. Thus, early 
(e.g., Crx-positive) photoreceptor precursors that might have integration potential after 
transplantation [17] are not included in the sorted cell fraction. In addition, more mature 
photoreceptors that might have limited integration capacity [15] can still be present after 
enrichment. This might avert a higher integration rate of sorted cells. As a consequence, 
new cell surface antigens that specifically recognize photoreceptors at a developmental 
stage that represents the ideal characteristics for integration have to be identified and 
evaluated. Furthermore, identification of cell surface markers for the exclusive separation 
of rods or cones may be an essential prerequisite for the development of cell-based 
therapies for retinal degenerative diseases characterized by either rod, as in RP, or cone, 
as in AMD, loss.
! This study demonstrates that the enrichment of photoreceptor precursors from the 
neonatal mouse retina lead to increased integration into adult hosts. However, the 
absolute number of integrated donor photoreceptors remains relatively low (up to 3400 
cells). In comparison to other published reports, it is obvious that the variability of 
successful cell integration is relatively high between studies and even within the same 
study ([15-17,20,22,29] and this study). Such variability  may be due to diverse procedures 
and/or the techniques used, including cell dissociation, transplantation techniques, cell 
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reflux, genetic background, and age of donor and host mice, transgene reporters, and 
number of transplanted cells. However, enrichment of young photoreceptors could 
significantly increase the number of integrated cells ([17,29] and this study). Lakowski and 
colleagues reported 2010 integration numbers of 5,610 (median, range 754-15,402) cells / 
wt retina, using fluorescence-based sorting of Crx-GFP cells [17]. One year later, in 2011, 
they reported integration numbers of 13,134 (median, range 2,840-31,894) cells / wt retina 
using CD73-sorted Nrl-GFP cells [29], confirming our results of significant improvement of 
integration numbers using CD73-based cell surface antigen selection. Latest results by 
Pearson and colleagues indicate 16,759 ±  1,705 cells / wt retina using optimized 
transplantation procedures and 18,300 ±  1,474 cells per Gnat1-/- retina, a mouse model 
with no rod function but also no retinal degeneration [19].
! In conclusion, the optimization and standardization of the entire transplantation 
process is of prime importance in bringing photoreceptor replacement closer to a clinical 
application, keeping in mind that the combined data reveal that the integration of a couple 
of thousand donor photoreceptors after transplantation into mouse models of retinal 
degeneration is still inefficient to cause functional changes that can be measured by 
electroretinogram ([17] and Ader M, unpublished data, 2010). Indeed, Pearson and 
colleagues reported recently, that 150,000 but not 60,000 rods are sufficient to elicit a 
reliable scotopic ERG response in Gnat1-/- mice [19]. Additionally, they reported a 
functional response in treated Gnat1-/- mice using a new water-maze setup, indicating that 
ERG measurements might be not sensitive enough to detect the currently small beneficial 
effects of PPC transplantation. In future, the purification of transplantable photoreceptors 
might be combined with methods that allow higher integration rates. For instance, these 
might include manipulation of the host tissue by acutely disrupting the outer limiting 
membrane using RNA interference technology [20,21], immune modulation [22,37], or co-
injection of factors, allowing increased donor [38] cell migration and synapse formation like 
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MMP-2 or chondroitinase ABC [37,39]. Furthermore, it may be important to increase 
survival rates of transplanted photoreceptors [23,40] or implant donor cells into the sub-
retinal space in a more oriented fashion instead of cell suspensions [41].
! In conclusion, these results demonstrate the efficient enrichment of transplantable 
photoreceptors from the developmental mouse retina using cell surface-specific 
antibodies. Enriched cell fractions integrated with a significantly higher number into the 
ONL of adult hosts, generating mature, OS-forming photoreceptors. Thus, cell surface 
antigen-based enrichment of young photoreceptors represents a new and reliable method 
for cell transplantation studies to treat retinal degeneration characterized by photoreceptor 
cell loss.
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3) Cell therapy: Outer segment formation of 
transplanted photoreceptor precursor cells
3.1) Introduction
While in the first part of this work, a quantitative enhancement of the integration capacity of 
transplanted photoreceptor precursor cells (PPCs) is investigated, the second part 
addresses the question of the quality of transplanted and integrated PPCs.
! In preclinical studies it was demonstrated that donor PPCs isolated directly from the 
neonatal mouse retina at postnatal day (PN) 3-5 have the highest potential to develop into 
mature photoreceptors [15-17,29], which form axonal terminals and inner (IS) and outer 
(OS) segments [30] following grafting into the retina of adult hosts. While a properly 
developed OS with well-aligned disc membrane staples is crucial for light detection and 
conversion into an electric signal, an axonal terminal that connects to the respective 
bipolar cell is indispensable for transmitting the electric signal to the host neural circuitry. 
Functional analyses, such as electroretinogram (ERG) recordings, pupillary reflexes, opto-
kinetic tracking or visual Morris water maze, have been described after transplantation of 
PPCs into murine models of retinal degeneration (RD) suggesting improvements in visual 
function [15,18,19,25,42]. Nevertheless, these studies still lack the direct morphological 
evidence for proper OS formation.
! Pioneer studies by Gouras et al. [11,43,44] and Bartsch et al. [16] suggesting OS 
formation of transplanted photoreceptors were impeded due to the lack of optimal labeling 
methods of donor OSs. Similarly, all other studies on photoreceptor transplantation failed 
as well to demonstrate formation of OS due to the absence of fluorescent reporter proteins 
in the OS of transplanted PPCs [15-17,19,29]. Here, I took advantage of a recently 
generated transgenic reporter mouse line in which enhanced green fluorescent protein 
(EGFP) is fused to human rhodopsin protein, the main photopigment in rod photoreceptors 
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[33], to investigate these issues. Rhodopsin is exclusively located to the OS of mature rod 
photoreceptors allowing detailed ultra-structural analysis of their formation and integrity 
upon the transplantation of PPCs into adult mouse retinas. Using such model organisms 
combined with the isolation of PPCs based on CD73 as a cell surface marker I 
successfully  demonstrate that transplanted PPCs are able to form a native OS including 
the formation of a connecting cilium and well-aligned disc membrane staples, the latter 
structure being an indispensable morphological prerequisite for proper light detection. 
Remarkably, the OS formation was not restricted to transplanted cells correctly integrated 
into the ONL but was also observed when photoreceptors remained in the sub-retinal 
space of the host.
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3.2) Results
3.2.1) Visualization of outer segments using fluorescence light and electron 
microscopy
Correlative light and electron microscopy (CLEM) investigations were performed in 
collaboration with Thomas Kurth and Susanne Kretschmar from the electron microscopy 
facility, CRTD, TU Dresden.
! CLEM combines fluorescent light microscopic (FLM) labeling with electron 
microscopy (EM), enabling studies of bulky  tissue samples from low to sub-cellular high 
resolution [45-47]. We took advantage of the CLEM flexibility to localize the rare events of 
PPC integration, and to study the formation of OS at an ultra-structural resolution.
! To demonstrate the feasibility of immuno-CLEM on retina samples as a proof of 
principle, adult eyes from a rhoEGFP mouse were isolated, embedded in Lowicryl K4M 
resin, and ultra-thin sections were immuno-labeled using anti-GFP antibodies (Fig. 10). 
The rhoEGFP transgenic animals were characterized by the expression of EGFP fused to 
human rhodopsin [33], which is exclusively located in the photoreceptor OS (Fig. 10A). As 
expected, a strong overlapping signal of rhoEGFP per se and the immuno-labeling (Fig. 
10B) was observed exclusively within OSs (Fig. 10C). At transmission electron microscope 
(TEM) level, sections derived from the same block labeled with anti-GFP antibodies 
followed by protein A 10-nm gold revealed that immuno-labeling is specific for 
photoreceptor OSs demonstrating that these light detecting structures can be visualized at 
an ultra-structural resolution based on a targeted EGFP expression (Fig. 10D, D’).
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Figure 10: Ultra-structural identification of outer segments from rhoEGFP transgenic mice. The 200-
nm thin K4M-resin sections of a retina isolated from an adult rhoEGFP mouse were immuno-stained with 
anti-EGFP antibodies followed by goat anti-rabbit Alexa555 (A-C). RhoEGFP fluorescence (A, green) is 
restricted to the outer segments (OS) of photoreceptors and completely overlaps with the immuno-
fluorescent signal (B, magenta; C is the merged image of A and B). Outer (ONL) and inner (INL) nuclear 
layers are highlighted by DAPI staining (blue). For ultra-structural analysis, resin sections from a rhoEGFP 
retina were immuno-stained with anti-EGFP antibodies, followed by protein A 10-nm gold (D; D’ is a high 
power image of the boxed region in D). Note the specific immuno-labeling of OSs containing the typical disc 
membrane staples characteristic for mature photoreceptors. CC, connecting cilium; IS, inner segment. Scale 
bars: A-C: 20 µm, D: 1 µm, D’: 500 nm. Adapted from Eberle et al., 2012.
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3.2.2) Transplanted photoreceptor precursor cells integrate into wild-type host 
retinas and form native outer segments with well-aligned disc membranes
To demonstrate whether PPCs transplanted into a wild-type (wt) retina develop  proper 
OSs, I used a dual strategy based on one hand on their paramagnetic immuno-isolation by 
means of CD73 as a selective cell surface marker [30], and on the other hand on double-
(actinDsRed, rhoEGFP) transgenic reporter animals, which allow to visualize the 
transplanted cells in the host wt retina. Indeed, the actin-driven DsRed expression 
highlights the entire cell body of transplanted PPCs with exception of the OS that is 
labeled by EGFP (i.e. rhoEGFP, see above). Donor PPCs were isolated from postnatal day 
(PN) 4 animals for all experiments in this study. 
! Three weeks post-transplantation, a sub-fraction of transplanted PPCs successfully 
integrated into the ONL of wt mice with an integration rate similar to our previous 
investigations, i.e. about 2000 ±  1000 cells/retina [30]. Donor cells showed DsRed-
expression in the whole cell body including the axonal terminal connection within the outer 
plexiform layer (OPL) (Fig. 11A, white), while rhoEGFP-expression was detectable 
exclusively in elongated, tubular structures of approximately 5-15 µm length and 1 µm 
width apical to the rest of the cell body (Fig. 11A, green). Since the latter structure has the 
typical shape and localization of a photoreceptor OS, it is highly probable that transplanted 
PPCs develop  an OS, too. CLEM analysis of single ultra-thin sections mounted to finder 
grids (Fig. 11B) revealed rhoEGFP–positive elongated tubular structures (Fig. 11B’: boxed 
area in B; Fig. 11C, C’, arrow). 
! At high-resolution level, these fluorescent structures (e.g. see Fig, 11D’, arrow) 
turned out to be morphologically normal OSs (Fig. 11D, TEM-micrograph corresponding to 
FLM image in D’). Thus, OSs of the transplanted cells displayed well-aligned disc 
membranes growing out from a connecting cilium (Fig. 11E-E”). Although the overall 
membranous organization of the vast majority (20 out of 21) of analyzed transplanted 
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rhoEGFP–positive photoreceptor OSs was indistinguishable to that of native photoreceptor 
cells found in the host retina (Fig. 11F), we observed in few cases donor cells harboring 
slight disturbances of the alignment of disc membranes within OSs (data not shown). Such 
phenomena might be the result of the sample preparation or might represent individual 
cellular variances, since they were also observed in rare cases in host photoreceptor OSs. 
! Technically, it is important to point out that a careful observation and interpretation 
of fluorescent OSs are crucial since certain unidentified auto-fluorescent structures in the 
area of host OSs (Fig. 11B’, C, arrowhead), might correspond to false–positive signals as 
detected by TEM (Fig. 11C’). Taken together, we demonstrated technically a powerful 
method to analyze the ultra-structure of the OSs of transplanted PPCs into host retinas, 
and revealed from a cell biological point of view that PPCs integrated into the host ONL 
are able to develop morphologically normal OSs.
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Figure 11: Integrated donor rhoEGFP–positive photoreceptors generate outer segments in wild-type 
host retinas.
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Figure 11: Integrated donor rhoEGFP–positive photoreceptors generate outer segments in wild-type 
host retinas. Upon transplantation into an adult wild-type mouse (A), CD73-enriched photoreceptor 
precursor cells (PPC) isolated from double-transgenic (rhoEGFP, actinDsRed) reporter animals integrated 
properly into the host retina and developed the typical morphology of mature photoreceptors, including a 
round cell body (CB, white) located in the outer nuclear layer (ONL), an axonal terminal (AT) in the outer 
plexiform layer (OPL) as well as an inner (IS, white) and outer (OS, green) segment located above the outer 
limiting membrane (OLM, dashed line). On a representative correlative light electron microscopy section (B; 
B’ is a higher power view of the boxed area in B) rhoEGFP–positive elongated structures could be observed 
(B’, arrow). Cell nuclei are stained with DAPI (blue). Note that not every green fluorescent signal in the area 
of host OSs indicated the presence of biological structures since unspecific signals (B’, C and C’, arrowhead) 
could mimic the typical ones of a rhoEGFP–positive OS (C, arrow), which was not observable in low-
magnification transmission electron microscopy (TEM) in contrast to the contamination (C’, arrow and 
arrowhead, respectively). RhoEGFP–positive OSs derived from integrated, transplanted PPCs showed the 
physiological elongated morphology as observed by TEM (D, blue dashed line; E) and the corresponding 
fluorescent light microscopy image (D’, arrow; as reference points three nuclei were numbered). The boxed 
areas in E are shown at higher magnification in the respective panels E’ and E”. Note that in addition to the 
formation of a connecting cilium (E’’, CC) the donor-derived OSs displayed growing membrane evaginations 
at their bases (E”, bracket) and typical densely packed disc membrane staples (E’, E’’) similar to 
endogenous OSs (F). Scale bars: A: 10 µm, B: 50 µm, B’-C’: 20 µm, D: 10 µm, E: 1 µm, E’-F: 500 nm. 
Adapted from Eberle et al., 2012.
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3.2.3) Non-integrated cells in the wild-type sub-retinal space develop an outer 
segment
Several studies suggest that transplanted photoreceptors form OSs when integrating into 
the ONL of experimental animals [15,16,19,30,43,44]. However, patients with severe RD 
are characterized by an almost absence of photoreceptor cells and are thus missing a 
proper ONL structure that would allow integration of donor cells. Indeed, the integration 
rate of transplanted PPCs strongly decreases in mouse models of RD characterized by a 
severe loss of the ONL ([48,49] and see below) and non-integrated donor photoreceptors 
fail to form the typical elongated morphology of mature wt photoreceptors. Also, following 
transplantation into a normal environment, the majority  of grafted photoreceptors remains 
in the sub-retinal space and does not develop photoreceptor morphology [16]. 
! Using CD73-enriched donor cells isolated from double-(actinDsRed, rhoEGFP) 
transgenic reporter mice I observed that transplanted cells located in the sub-retinal space 
of wt hosts do not develop the elongated morphology of integrated photoreceptors as seen 
in Figure 11A. In contrast, I observed round DsRed–positive cell bodies with adjacent 
longitudinal, EGFP–positive, OS-like structures (Fig. 12A, arrows). Ultra-structural analysis 
revealed that EGFP–positive extensions were native-like OSs containing well-aligned disc 
membrane staples (Fig. 12B-B”) in the majority of studied OSs (35 out of 40). Therefore, I 
conclude that donor photoreceptors not only form native-like OSs when correctly 
integrating into the ONL of the host but also when remaining in the sub-retinal space.
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Figure 12: Transplanted photoreceptors remaining in the sub-retinal space generate outer segments. 
Upon transplantation into an adult wild-type mouse (A), many CD73-enriched photoreceptor precursor cells 
(PPC) isolated from double-transgenic (rhoEGFP, actinDsRed) reporter animals remain in the sub-retinal 
space (SRS) at the top  of the host outer nuclear layer (ONL, dashed line) and develop  outer segment (OS)-
like structures that are labeled with rhoEGFP (green, arrows). The cell body of transplanted cells is observed 
by DsRed-expression (magenta) whereas cell nuclei are stained with DAPI (blue). An electron microscopy 
overview (B) of transplanted PPCs found in the SRS demonstrates that several of them (asterisks) lay above 
the host photoreceptor OSs, which are delimitated by a dashed line. Magnifications of the boxed areas in 
panel B reveal that the non-integrated PPCs developed as well organized disc membrane staples, which are 
positive for rhoEGFP (B’, B”, black dots). Scale bars: A: 10 µm, B: 5 µm, B’ and B”: 2 µm. Adapted from 
Eberle et al., 2012.
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3.2.4) Transplanted photoreceptor precursor cells do not integrate in P347S host 
retinas but form outer segments in the sub-retinal space
In the previous sections we have shown that PPCs have the potential to form OSs when 
integrated into the ONL or remaining in the sub-retinal space of wt hosts. Based on these 
results, I further investigated whether a similar phenomenon might occur in severely 
degenerated retinas. P347S transgenic mice represent a valuable model for autosomal-
dominant retinal degeneration, and heterozygous animals loose the majority of 
photoreceptors within 12 weeks ([50], our unpublished observations). 
! Following transplantation of CD73-enriched PPCs derived from double-
(actinDsRed, rhoEGFP) transgenic mice into heterozygous P347S mouse retinas (4 and 
12 weeks old), I observed the formation of cell clusters located in the sub-retinal space 
(Fig. 13A). Integration of grafted cells into the remaining ONL, which consists solely of 1 or 
2 nuclei thickness in 12 weeks old mice, was not observed three weeks post-
transplantation (Fig. 13A). Nevertheless, the majority of donor photoreceptors had formed 
longitudinal, rhoEGFP–positive OS-like structures next to their DsRed-positive cell bodies 
(Fig. 13A‘) as observed above upon transplantation in healthy animals. We could not 
observe a consistent OS polarity, neither towards the RPE nor the ONL, of sub-retinal 
located donor cells in wt as well as in p347s animals. Electron-microscopic analysis 
revealed the formation of OSs with well-aligned disc membranes (in 8 out of 16 examined 
sub-retinal OSs), demonstrating the potential of transplanted PPCs to form native OS 
structures in a heavily  degenerated retina, and this without cellular integration into the host 
tissues (Fig. 13A‘‘, A‘‘‘).
! To evaluate if such sub-retinal located donor photoreceptors are light-sensitive we 
analyzed the sub-cellular localization of transducin, a molecule of the light transduction 
pathway that is present in the OS in the dark and translocates to the inner segment/cell 
body upon light stimulation. Indeed immuno-histochemical analysis showed that transducin 
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is predominantly present in OSs of donor photoreceptors in dark-adapted mice (Fig. 13C - 
C’’’) whereas in light-adapted mice, it could only  be detected in the cell body (Fig. 13B – 
B’’’). Furthermore, as rhodopsin represents the first protein in the light transduction 
pathway and has to be highly expressed in functional photoreceptors, we analyzed the 
generation of rhodopsin by immuno-histochemistry to determine its expression at the 
protein level. Indeed, labeled donor photoreceptors showed similar fluorescence 
intensities as endogenous photoreceptors in all transplantation paradigms (Fig. 14).
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Figure 13: Transplantation of rhoEGFP–positive photoreceptors into the degenerated retina of 
heterozygous P347S mice. Low and high magnification views (A, A‘) of a degenerated retina from a 
heterozygous P347S mouse, 3 weeks post-transplantation of CD73-enriched photoreceptor precursor cells 
isolated from double-transgenic (rhoEGFP, actinDsRed) reporter animals. Cell nuclei are stained with DAPI 
(blue). Note, that transplanted cells (cell body, magenta; outer segment, green) are found in a sheet-like 
structure in the sub-retinal space (SRS), i.e. above the host outer nuclear layer (ONL), which is reduced to 
only 1 - 2 cell rows. Electron microscopy analyses of rhoEGFP–positive structures reveal the formation of 
ultra-structurally normal OSs containing morphologically native disc membrane staples (A'', A'''). In light 
adapted animals (B-B'''), transducin (B'', white and B''', magenta) is expressed in OSs of transplanted, sub-
retinal PPCs at low levels (B' and B'', arrows), whereas high levels of transducin could be detected in IS-like 
structures next to rhoEGFP-positive OSs (B' and B'', arrowhead). In contrast, dark adapted animals show 
significantly higher levels of transducin in rhoEGFP-positive OSs (C' and C'', arrows), indicated also by white 
overlay staining in C'''. This illustrates, that sub-retinal PPCs show the native translocation of transducin 
under different light conditions, which is a prerequisite for functionality. INL, inner nuclear layer. Scale bars: 
A: 50 µm, A': 10 µm, A'', A''': 500 nm, B-B''' and C-C''': 10 µm. Adapted from Eberle et al., 2012.
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Figure 14: Rhodopsin expression in rhoEGFP-positive OSs.
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Figure 14: Rhodopsin expression in rhoEGFP-positive OSs. Rhodopsin expression was detected in 
rhoEGFP-positive OSs of integrated donor cells in wt (A-A''') as well as in rhoEGFP-positive OSs of sub-
retinal located cells in P347S mice (B-B'''). DsRed-positive, transplanted PPCs (A, magenta) show, following 
integration into the host wt ONL, typical green fluorescent, rhoEGFP-positive OSs at the tip  of their ISs (A, A', 
white and A''', green) highlighted by arrows in A-A'''. Rhodopsin staining (A'', white and A''', magenta) reveals 
a relatively equal expression throughout the OSs of the wt host. The rhoEGFP-positive OSs co-localize with 
rhodopsin immuno-staining (compare A' and A'', arrows), indicated by white overlap  staining in A''' (arrows). 
Following transplantation into P347S mice sub-retinal located DsRed-positive PPCs (B, magenta) develop 
the characteristic rhoEGFP-positive OSs adjacent to the cell body (B, B', white and B''', green). The 
rhoEGFP fluorescence co-localizes with rhodopsin staining (compare B' and B'', arrows), indicated by white 
overlap  staining in B'''. Similar rhodopsin expression levels are detectable in host and donor cells (A, B) 
suggesting a native expression of rhodopsin in rhoEGFP-positive OSs of transplanted and integrated as well 
as sub-retinal located PPCs. Scale bars: 10 µm. Adapted from Eberle et al., 2012.
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3.2.5) The sub-retinal space provides a supporting environment for outer segment 
generation of transplanted photoreceptor precursor cells
The data presented above demonstrate, that PPCs located to the sub-retinal space of 
both, wt and degenerated retinas, develop native-like OSs. This prompted me to 
investigate whether the OS formation by transplanted donor cells is a cell autonomous 
property or depends on environmental factors. To address this issue, I injected 
simultaneously donor PPCs into the sub-retinal space and the vitreous side of four-weeks 
old P347S transgenic hosts (Fig. 15).
! As shown above, PPCs located in the sub-retinal space developed the typical OS-
like structures with high-levels of rhoEGFP expression (Fig 15A, A’). In sharp contrast, 
when transplanted to the vitreous side, donor cells expressed significant lower amounts of 
rhoEGFP (Fig. 15A). Indeed, EGFP-positivity of vitreal located donor PPCs could only be 
visualized by increasing the saturation level of the green fluorescence channel of the same 
image (Fig. 15B; B’ is a higher magnification of the boxed area in B). Furthermore, FLM 
analyses suggested that in comparison to PPCs injected to the sub-retinal space (Fig. 
15A’), the ones located on the vitreous side generated OS-like structures less frequently 
(Fig. 15B’, arrows; ultra-structurally 7 out of 16 analyzed donor cells showed an OS-like 
structure) and that these were poorly  developed (Fig. 15B’; see also Fig. 16A, B). CLEM 
analysis revealed that these structures are, in all cases (7 out of 7), altered OSs with 
abnormal arrangement including disorganized disc membrane staples (Fig. 16D, E). 
Occasionally, we observed a mis-localization of rhoEGFP to the plasma membrane of the 
soma (Fig. 16F). Taken together, these findings indicate that the sub-retinal space, in 
contrast to the vitreous one, supports the maturation of transplanted PPCs and proper 
biogenesis of OSs.
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Figure 15: Differences in outer segment formation between sub-retinal and vitreal located 
transplanted photoreceptor precursor cells. CD73-enriched photoreceptor precursor cells (PPC) isolated 
from double-transgenic (rhoEGFP, actinDsRed) reporter animals were simultaneously transplanted into the 
sub-retinal (SRS) and vitreous (VS) space of 4-weeks old P347S hosts (A; B  is the same image as A but with 
increased green fluorescence channel saturation level). Cell nuclei are highlighted with DAPI staining (blue). 
Donor cells (magenta) were detected in the SRS (e.g. boxed area in A) and VS (A and B, arrow) showing 
survival of transplanted cells in both locations. Whereas sub-retinally injected PPCs showed strong EGFP 
expression (green; e.g. boxed area in A), vitreally injected donor cells appeared almost devoid of EGFP 
signal (A, arrow). However, by increasing the saturation level of the green fluorescence signal channel in 
image A, faint EGFP signal could be detected in the vitreally located donor cells (B; B’ is a separate image 
with adjusted shutter time showing a magnification of the boxed area in B) demonstrating that donor cells 
located in the SRS had higher rhoEGFP expression levels than those in the VS (compare different cell 
populations in each individual panel A and B). Moreover, almost every single sub-retinal located donor PPC 
showed rhoEGFP labeled OSs (A’), in contrast to those located in the VS that generated only in few cases 
OS-like protrusions (B’, arrows). ONL, outer nuclear layer; INL, inner nuclear layer. Scale bars: 50 µm. 
Adapted from Eberle et al., 2012.
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Figure 16: Vitreal-located transplanted photoreceptor precursor cells develop disturbed outer 
segment-like structures with misaligned disc membranes.
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Figure 16: Vitreal-located transplanted photoreceptor precursor cells develop disturbed outer 
segment-like structures with misaligned disc membranes. CLEM analysis on resin sections allowed 
examination of vitreally-transplanted rhoEGFP–positive photoreceptor precursor cell aggregates. Cell nuclei 
are highlighted by DAPI staining (blue). A representative example is shown with fluorescence light 
microscopic- (A) and transmission electron microscopic-illumination (A’). The donor cells in A and A’ are 
shown at higher magnification in the respective panels B and B’. RhoEGFP-enriched structures (A, B; green, 
arrows) next to the cell bodies suggest the formation of OSs, and three of these (C, D and E) are displayed 
in the corresponding panels at a high-resolution level by TEM-analysis. These structures appear either as 
rhoEGFP-enriched cell debris (C) or rhoEGFP–positive OS-like structures with an abnormal organization/
integrity including misaligned disc membranes (D, E). Additionally, mislocation of rhoEGFP to the plasma 
membrane of the soma was observed (F). Scale bars: A, A’: 20 µm, B, B’: 10 µm, C: 1 µm, D-F: 500 nm. 
Adapted from Eberle et al., 2012.
48
3.3) Discussion
In the present study, a unique system that combines the use of transgenic mouse lines 
and CLEM to analyze the peculiar morphological details of the OS structure of 
transplanted PPCs is reported. Three major cell biological observations were made using 
such bio-technical tools. First, we demonstrated that integrated PPCs develop  into mature 
photoreceptor cells with appropriate OS structures. Second, we show that PPCs remaining 
in the sub-retinal space of wild-type as well as degenerated retinas generate also proper 
OSs and third, we revealed that environmental factors found in the sub-retinal space 
influence PPC differentiation and maturation.
! PPCs have been studied as a possible therapeutic option for the replacement of 
lost photoreceptors in pre-clinical mouse models since their first successful transplantation 
already two decades ago [12,13,43,44]. Recent reports have revealed their ability to 
integrate and differentiate into mature photoreceptors when transplanted into host retinas 
[15,16,19]. Indeed, studies indicated that upon integration into the host ONL donor PPCs 
develop adequate axonal terminals containing ribbon synapses located in the OPL 
whereas their ISs and OSs lie in the photoreceptor layer just above the outer limiting 
membrane [15,16,30]. Direct evidence for proper OS formation was however impeded due 
to the lack of adequate transgenic animal models allowing the accurate tracking of 
transplanted cells [15,16,19,29]. For instance, most of the studies used soluble, 
cytoplasmic fluorescent reporter proteins, which in essence strongly limits their targeting 
towards the photoreceptor OS. Addressing the latter issue is particularly important given 
that the key feature of photoreceptors enabling correct light detection relies on the aligned 
disc membrane staples of their OS.
! To settle such technical difficulty we used here transgenic animals as a source of 
donor cells where prospective OSs of transplanted cells could be visualized with a 
fluorescent reporter protein specifically  targeted to the OSs by means of rhodopsin as a 
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carrier protein. By  combining CLEM with indirect immuno-labeling of the reporter-fusion 
rhodopsin-EGFP protein we demonstrated that integrated donor PPCs develop OSs with 
proper morphological structures that included the formation of a connecting cilium followed 
by aligned disc membrane staples. Moreover, short membrane evaginations growing from 
the connecting cilium at the base of OSs are detectable, consistent with the normal 
biogenesis of these photoreceptive structures. In addition, our investigations reveal 
unexpectedly that transplanted PPCs, which are not integrated into the host ONL, but 
remained in the sub-retinal space, generated also proper OSs. This observation is 
independent from the degenerative state of the host retina since a similar phenomenon 
was detected when PPCs were transplanted into severely degenerated retinas of P347S 
transgenic mice. Therefore, it appears that the formation of normal OSs from transplanted 
PPCs is independent of their integration into the ONL.
! The cell biological properties of transplanted PPCs to form proper OSs 
independently  of their integration within the host ONL may rely  either on cell autonomous 
cues or cellular factors provided by the microenvironment found in the host retinas. To 
further dissect these possibilities, I have differentially transplanted the PPCs into the sub-
retinal space and vitreous side. Interestingly, we found that PPCs transplanted into the 
vitreous side express significant lower amounts of rhodopsin-EGFP and develop aberrant 
OSs by comparison to those injected to the sub-retinal space. Such data suggest that the 
maturation of PPCs as monitored by the expression of rhodopsin and formation of OS are 
provided by  factors found specifically in the sub-retinal space. One major cellular player 
that could explain such singularity is the retinal pigment epithelium (RPE) adjacent to the 
sub-retinal space. Indeed, RPE cells have been shown to promote photoreceptor cell 
development, survival, neurite outgrowth and differentiation [51-53] as well as OS 
development, maintenance and regeneration [54,55]. A direct connection of donor OSs 
with endogenous RPE cells does not seem to be necessary since OS formation is 
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observed throughout the sub-retinal PPC population even when forming multiple layers of 
cells. As a consequence, I propose that factors secreted from the RPE have an important 
influence on the stimulation of transplanted PPCs to mature and form OSs. However, a 
correct alignment and growth towards the RPE was not observed. We therefore conclude, 
that these factors stimulate maturation and formation of OSs but are not sufficient for their 
correct alignment. Since in eye development the outgrowing OSs are tightly packed next to 
each other, it might be important for future studies to provide a scaffold for correct 
alignment and targeting of OSs developed by sub-retinal located PPCs.
! The findings of this study are of prime importance to further develop  this promising 
treatment strategy towards clinical application. Indeed, photoreceptor cell-based 
replacement therapy is founded on three main pillars. First, it is indispensable to establish 
a reliable and continuous source for transplantable materials. Second, a transplantation 
method providing a significant number of integration events and long-term survival of 
donor cells is a technical pre-requisite, and third, maturation including OS formation and 
functional integration of donor PPCs into the neural circuitry of the host retina are a must. 
Several teams are currently  investigating the potential of diverse in vitro expandable cell 
populations for the generation of transplantable photoreceptors. These cell sources 
include i) expandable cells isolated from the retina, the so-called “retinal stem 
cells” [56-59] and ii) pluripotent stem cells, i.e. embryonic stem cells (ESC) [18,24] and 
induced pluripotent (iPS) stem cells [25,42,60]. Whether such produced or manufactured 
donor photoreceptors have however the potential to generate proper OS structures 
following grafting as demonstrated here for PPCs remains to be evaluated. Obviously, the 
double-(actinDsRed, rhoEGFP) transgenic animals might be used as cellular sources to 
generate such in vitro expandable donor cells to solve such issues.
! Finally, I have documented that PPCs transplanted to the sub-retinal space have 
the potential to form proper photoreceptor OSs even when they are not integrated into the 
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host ONL. A phenomenon observed as well in RD models (e.g. P347S: this work; 
rhodopsin knock-out: our unpublished observations). However, the lack of integration into 
the latter models raised some biomedical questions. Barber and colleagues have also 
linked a negative correlation between grade of degeneration and integrative potential into 
the host ONL in most retinal degeneration models studied [48,49]. Such issues are 
particularly important when we are thinking about patients at late stage RD, i.e. who are 
blind or close to blindness and show a strong, if not a total degenerated ONL. Although, it 
appears unlikely  at first glance that transplanted PPCs will successfully integrate into 
degenerated retinas of such affected patients (this study and [48,49]), a recent study 
demonstrated that following transplantation into a slow degeneration mouse model of RP 
(i.e. Gnat1-/- mice), PPCs are able to integrate into the host ONL and functionally connect 
to the neural circuitry by forming active synapses with endogenous interneurons [19]. 
Together with our results demonstrating OS formation and light sensitivity of donor 
photoreceptors in strongly degenerated retinas without integration, such achievements 
indicate that visual improvement might also be possible in late stage retinal degenerations. 
However, detailed investigations of functional integration of donor cells into the host neural 
circuitry at the cellular and behavioral level still have to be performed to evaluate the 
potential of transplanted photoreceptors in the heavily degenerated retina. Collectively, 
these findings represent a major step on the way towards the development of a cell-based 
replacement therapy of diseases characterized by photoreceptor loss.
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4) Gene therapy: Rescue of prominin-1 knock-out 
mouse phenotype by introducing wild-type prominin-1 
using rAAV vectors
4.1) Introduction
After qualitative and quantitative investigations for a cell therapy, the third part of this work 
addresses a gene therapeutical approach for retinal degenerative disorders.
! To date, mutations in 69 different genes have been identified to cause retinitis 
pigmentosa (see RetNet: https://sph.uth.tmc.edu/retnet/). Among these, Prominin-1 
(PROM1, AC133, CD133, PROML1) is a promising candidate for the development a gene 
therapy. Particularly, children which are born with mutations in prominin-1 are of main 
interest for such therapy since their retina still contains a high amount of photoreceptors 
suitable for prominin-1 gene delivery. Prominin-1 is a 5-transmembrane-domain 
glycoprotein (Fig. 17A) located at plasma membrane protrusions and expressed in various 
tissues. Recent results indicate that Prominin-1, which is located at the tip  of the 
connecting cilium, apical to the photoreceptor inner segment (IS), plays a central role in 
photoreceptor outer segment (OS) disc morphogenesis ([61], see also Fig. 17B).
!
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Figure 17: Prominin-1 - 
structure and cellular 
localization. Prominin-1, 
a 5 - t r a n s m e m b r a n e 
domain glycoprotein (A) is 
expressed at the base of 
the outer segment (OS) of 
mature photoreceptor 
cells (B, cartoon of a rod 
cell). In this region, outer 
segment (OS) discs start 
to grow out and new disc 
membrane staples are 
formed. 
To date, six different mutations in human prominin-1 are known, causing a variety of retinal 
degenerative disorders ranging from Stargardt-like via bull‘s eye macular dystrophy  and 
cone-rod dystrophy to retinitis pigmentosa (Tab. 2). Five of the six mutations are known to 
be autosomal recessive with four of them affecting the open reading frame [62-65] and 
one, predicted to cause a splice defect [66]. The last one of the six mutations is reported to 
be autosomal dominant [67-70]. In focus of this study are the autosomal recessive 
mutations where the phenotype is caused by the absence or non-functional presence of 
the protein at its native final location, the plasma membrane.
! For ocular gene delivery, recombinant adeno-associated viral (rAAV) vectors are 
most widely used and studied [8-10]. Their proven long-term transgene expression and the 
fact, that they may generate only  minor immune responses, highlights them as ideal 
delivery vehicles. Different retinal cell types could be selectively addressed by using 
specific serotypes [71-73] and recent approaches focus on engineering new, artificial 
serotypes for even more specific targeting [74]. Functional rescue of photoreceptor cells in 
animal models of recessive Leber congenital amaurosis [75-77] and achromatopsia [78] as 
well as autosomal dominant [79,80], recessive [81] and X-linked retinitis pigmentosa [82] 
has been demonstrated recently.
! Here, I follow these studies on the background of autosomal recessive Prominin-1 
deficiencies. A delivery of wt prominin-1 to diseased host photoreceptor cells using rAAV 
vectors should theoretically lead to a rescue of the retinal degenerative phenotype. The 
animal model used in this study, the prominin-1 knock-out mouse, displays only 
disorganized OS discs and retinal degeneration [61]. Taken into account that prominin-1 is 
expressed in various cell types, including stem cells, this defined phenotype is a 
remarkable and unexpected finding and highlights the fact, that mutations and deletions of 
prominin-1 are only affecting photoreceptor cells. Retinal degeneration starts in prominin-1 
knock-out mice at post-natal day 15 with an initially severe loss of ∼50% of all 
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photoreceptor cells within 5 days while slowing down later in a logarithmic curve until total 
degeneration of the ONL with the age of 12 months [61]. This loss of photoreceptors over 
time mimics the phenotype known from human prominin-1 mutations. For the development 
of a gene therapy, I tested, whether it is possible to rescue the knock-out phenotype by 
delivering wt prominin-1 to the host photoreceptors using serotype 2/5 and 2/8 rAAV 
vectors.
autosomal dominant
reported genomic locus author year reported phenotype PubMed ID
1117C>T
Yang Z 2008 macular degeneration 18654668
Michaelides M 2010
bull's eye maculopathy 
associated with rod, rod-cone, 
and macular dystrophy
20393116
Chromosome 4p, 12-cM interval 
between loci D4S1582 and 
D4S2397, defined as STGD 4 locus
Kniazeva M 1999 stargardt-like disease 10205271
Chromosome 4p15.2-16.3, between 
loci D4S3023 and D4S3022, 
overlapping the STGD 4 locus
Michaelides M 2003 bull's-eye macular dystrophy 12657606
autosomal recessive
reported genomic locus author year reported phenotype PubMed ID
1878delG Maw MA 2000 retinal degereration 10587575
1726C>T Zhang Q 2007
severe form of retinitis 
pigmentosa accompanied by 
macular degeneration
17605048
1349insT Pras E 2009 cone-rod dystrophy and high myopia 19718270
869delG Permanyer J 2010
retinitis pigmentosa with 
premature macular atrophy and 
myopia
20042663
1142-1G>A Littink KW 2010 cone-rod dystrophy 20554613
Table 2: Reported human mutations in Prominin-1. Reported genomic loci from Kniazeva et al., 1999 and 
Michaelides et al., 2003 overlap  at the STGD 4 locus and are most likely the same. This locus seems to be 
the 1117C>T locus reported by Yang et al., 2008 and Michaelides et al., 2010, later (Denis Corbeil, personal 
communication). This reduces the number of reported autosomal dominant human Prominin-1 mutations to 
one, whereas all five autosomal recessive mutations refer evidentially to different loci as reported by Maw et 
al., 2000; Zhang et al., 2007; Pras et al., 2009; Permanyer et al., 2010 and Littink et al., 2010. The 
1142-1G>A mutation is predicted to impair splicing and is not affecting the open reading frame, like the other 
reported mutations.
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4.2) Results
4.2.1) Targeting specificity and expression profile of rAAV-constructs
For viral vector therapies, vector targeting specificity and efficiency is of prime importance. 
Since AAV serotypes 2/5 and 2/8 have been shown to target photoreceptor cells [71-73], I 
tested them as GFP-expressing vectors, driven by an ubiquitously active CMV promoter 
with sub-retinal delivery on wild-type retinas. There, they display  high photoreceptor 
specificity and a strong, injection-site restricted transgene expression with minor, non 
significant differences between them (Fig. 18B). In few cases (< 0.1%), single Müller-glia 
cells or second order neurons were targeted (see appendix Fig. S1). Under native 
conditions prominin-1 is selectively expressed at plasma membrane protrusions of various 
cell types, and in photoreceptors it is concentrated at the base of the OS (Fig. 18A) [63]. 
By transducing wt retinas with rAAV2/5 vectors expressing a prominin-1::GFP fusion 
construct, where GFP is translationally fused to the C-terminal domain of prominin-1, I 
could show an exclusive localization to the inner and the base of the OS in wild-type 
animals (Fig. 17C), which corresponds partly with the wt expression (compare Fig. 17A 
and C). In a previous study, it was demonstrated that GFP protein fused to the C-terminus 
of prominin-1 did not interfere with its proper targeting to plasma membrane protrusions 
such as microvilli of polarized epithelial cells [83]. The detection of prominin-1::GFP in ISs 
revealed its correct intracellular transport within cellular compartments (e.g. ER, Golgi) en 
route to the cell surface [83].
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F i g u r e 1 8 : P r o m i n i n - 1 
expression and viral vector 
based delivery  to a wild-type 
retina. Prominin-1 is expressed 
at the tip  of the inner segment 
(IS) of mature photoreceptor 
cells, which can be labeled by 
recoverin (A, IS, magenta) The 
insert in A shows a high power 
image of the IS region. In this 
region, adjacent OS discs start to 
grow out and new disc membrane 
s t a p l e s a r e f o r m e d . T h e 
transduction rate of rAAV2/5 and 
rAAV2/8 was tested with GFP-
expressing vectors on wt retinas 
( B , g r e e n ) . I n g e n e r a l , a 
transduction efficiency of approx. 
50 - 80% of all host outer nuclear 
layer (ONL) cells could be 
achieved. With a specificity of 95 
- 100% for photoreceptor cells, 
rAAV2/5 and rAAV2/8 vectors 
have proven them suitable for 
photoreceptor gene therapy. 
Proper translocation of the 
Prominin-1 construct to the outer 
segment was tested with a 
rAAV2/5-vector expressing a 
Prominin-1::GFP fusion protein. 
After sub-retinal delivery, strong 
GFP exp ress ion cou ld be 
detected in ISs as well as in OSs 
(C, green) of host photoreceptor 
cells. INL: inner nuclear layer, A-
C: 30 µm vibratome sections, 
scale bar: 20 µm
4.2.2) Short-term effects of prominin-1-delivery to the prominin-1 knock-out retina
The data obtained so far promoted me to investigate the possibility to rescue the retinal 
phenotype observed in prominin-1 knock-out mice. Remarkably, delivery of prominin-1 
alone (i.e. without GFP fused to it) to a post-natal day 15 old prominin-1 knock-out mouse 
resulted in strong expression of Prominin-1 protein at its native sub-cellular location, i.e. 
the base of the photoreceptor OS, in contrast to results from prominin-1::GFP 
transductions (compare Fig. 18A and Fig. 19C‘‘ with Fig. 18C). Prominin-1 expression was 
first detectable 2 weeks after injection (Fig. 19B). Morphological differences in ONL 
thickness between injected and non-injected eyes first occurred 3 weeks after injection 
(Fig. 19C). The results indicate a thicker ONL in the area of prominin-1 expression, 
compared to areas devoid of it within the same retina (Fig. 19C‘,C‘‘). This leads to the 
conclusion that ectopic expression of prominin-1 in knock-out mice using rAAV-vector 
based delivery might rescue the effect of Prominin-1-deficiency resulting in photoreceptor 
survival and ONL preservation 3 weeks after treatment.
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Figure 19: Prominin-1 delivery  to 
the knock-out retina - 1-3 weeks 
post treatment. The expression of 
prominin-1 in knock-out mice was 
examined 1, 2 and 3 weeks after 
sub-retinal delivery to post-natal day 
15 mice. It was evaluated whether 
its expression has any effect on 
O N L t h i c k n e s s , i n d i c a t i n g 
p h o t o r e c e p t o r s u r v i v a l o r 
degeneration. After 1 week no 
expression was visible (A, green, 
nuclear marker DAPI in white) while 
after 2 weeks a strong anti-
Prominin-1 antibody staining could 
b e o b s e r v e d , c o v e r i n g 
approximately 1/3 of the retina (B, 
g reen ) . The ONL t h i c kness 
decrease slightly from 1 to 2 weeks 
post injection (compare A and B, 
white). After 3 weeks, prominin-1 
expression remains strong and 
restricted to the tip  of the IS region 
(compare B  and C, green). The 
thickness of the ONL remains 
unchanged in the area of prominin-1 
expression (C’’) compared with 2 
weeks post injection, whereas in 
non-transduced areas of the same 
retina a strong decrease in ONL 
thickness could be observed (C’). 
Th i s i s cons i s ten t w i t h t he 
untreated, contralateral control eye 
(not shown), indicating a protective 
effect of prominin-1 expression. 
I nse r t s i n C ‘ and C ‘ ‘ show 
magnifications of the inner segment 
region of respective pictures. IS: 
inner segment, ONL: outer nuclear 
layer, INL: inner nuclear layer; A-C‘‘: 
30 µm vibratome sections, scale 
bar: A-C: 200 µm, C’,C’’: 20 µm
4.2.3) Long-term effects of prominin-1-delivery to the prominin-1 knock-out retina
ONL preservation by prominin-1 delivery to a knock-out retina was shown on a short time 
period (i.e. 3 weeks after injection). Nevertheless, for therapeutical purposes, it is 
absolutely necessary  to show beneficial effects over a long period of time. To test this, we 
injected post-natal day 15 prominin-1 knock-out mice with rAAV2/8 vectors expressing 
native prominin-1. After 8 and 10 weeks, functionality  of photoreceptors was tested by 
electroretinogram (ERG) before examination of the histological structure of the retinas 
(Fig. 20). Treated retinas displayed strong prominin-1 expression in the area of the ISs 
(Fig. 20A-H, green, IS stained by recoverin, magenta). In contrast to short-term results 
shown above, I could not detect beneficial effects in any of the treated eyes. Indeed, 
treated eyes displayed impaired photoreceptor morphology  (highlighted by  recoverin 
staining in Fig. 20A-H). This could be observed especially when comparing the IS  structure 
between treated and untreated retinas (compare IS alignment and structure in Fig. 20A, C, 
E, G with B, D, F, H). Additionally, the thickness of the ONL was significantly thinner in 
treated eyes, compared to the contralateral untreated eye (compare ONL thickness in Fig. 
20A, C, E, G with B, D, F, H). These results are in line with functional results obtained from 
ERG measurements. While untreated eyes displayed a reduced ERG signal (Fig. 20B‘, D‘ 
F‘, H‘) compared to a normal wt signal (Fig. 20K), treated eyes displayed an even more 
reduced signal (Fig. 20A‘, C‘ , E‘, G‘), compared to untreated eyes and the wt animal. 
Notably, within the population of treated eyes, stronger degenerated retinas (Fig. 20A, E) 
displayed almost no ERG signal (Fig. 20A‘, E‘) while weaker degenerated retinas (Fig. 
20C, G) display at least a subtle signal in ERG measurements (Fig. 20C‘, G‘). This shows 
1), that rAAV2/8 mediated prominin-1 therapy of prominin-1 knock-out mice resulted in 
negative effects on a long timescale, especially  in respect to photoreceptor morphology 
and survival, and 2), that morphologically  stronger degenerated retinas show weaker ERG 
signals, which indicates in this case, that functionality  could be directly  correlated with 
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ONL structure and photoreceptor integrity. Since not all injections are equal in success, 
there might be also a correlation in injection quality and long-term survival of photoreceptor 
cells. Indeed, eyes with injections which were rated in personal documentations as 
qualitatively  good display better retinal structure and ERG signal (Fig. 20C, C‘ and G, G‘) 
than eyes with injections which were rated as qualitatively bad (Fig. 20A, A‘ and E, E‘). 
This highlights the importance of a save and minimal invasive ocular injection on the 
background of long-term retinal treatments in respect to viral vector deliveries as well as 
cell therapies.
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62Figure 20: Long-term study for prominin-1 delivery to the knock-out retina - 8-10 weeks post treatment.
Figure 20: Long-term study  for prominin-1 delivery  to the knock-out retina - 8-10 weeks post 
treatment. Long-term effects of prominin-1-delivery to the prominin-1 knock-out host animal retina via 
rAAV2/8-mediated viral vector treatment were examined 8 (animal 1 A, B; animal 2 C, D) or 10 weeks (W) 
(animal 1 E, F; animal 2 G, H) after injection. Since every host mouse was transduced with the age of post-
natal day 15, the mice were 10 or 12 weeks old, respectively, on the day of examination. Before examination, 
functional preservation of photoreceptor function was tested by electroretinogram (ERG, A‘-H‘, K: wt 
reference). In contrast to short-term results (see Fig. 18), long-term preservation could not be observed. 
Indeed, the delivery of prominin-1 (A-G, green) seem to have negative effects on photoreceptor morphology 
(A-D, recoverin staining in magenta) and survival (compare IS alignment and ONL thickness in A, C, E, G 
with B, D, F, H). This was verified by ERG measurements (compare A‘, C‘, E‘, G‘ with B‘, D‘, F‘, H‘). Note, 
that animals with strong degeneration profile on treated eyes (W8: A; W10: E) display almost no ERG  signal 
(W8: A‘; W10: E‘) while animals with weaker degeneration (W8: C; W10: G) display a subtle ERG signal (W8: 
C‘; W10: G‘). Nevertheless, this signal was smaller than the non-treated contralateral eye (compare C‘ with 
D‘ and G‘ with H‘). IS: inner segment, ONL: outer nuclear layer, INL: inner nuclear layer, nuclear DAPI 
staining shown in blue, ERG signals are shown as µV / ms graphs under different stimulus intensities from 
top to bottom: 0.0003, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3, 10 cd × s / m2, scale bars: 10 µm.
63
4.3) Discussion
Inherited retinal degenerative diseases like retinitis pigmentosa account for a significant 
amount of blind people in the world. It has been shown, that mutations in prominin-1, a 5-
transmembrane-domain glycoprotein expressed at plasma membrane protrusions, lead to 
severe visual impairment ranging from Stargardt-like via bull‘s eye macular dystrophy and 
cone-rod dystrophy to retinitis pigmentosa (Tab. 2). Viral vector based gene therapies 
represent today a promising tool for the treatment of inherited retinal diseases [8-10]. This 
study focusses on four of seven known mutations of prominin-1, which are known to be 
autosomal recessive [62-65]. There, the phenotype is caused by the absence or non-
functional presence of the protein, which makes them suitable for a gene therapy based 
on the delivery of wt prominin-1 to the patients‘ photoreceptors.
! To test the feasibility of such therapy, we delivered wt prominin-1 via rAAV-vectors 
to prominin-1 knock-out mouse retinas, which display retinal degeneration and 
disorganized disc membrane staples [61]. My initial studies showed, that the rAAV 
serotypes 2/5 and 2/8 display high photoreceptor specificity and strong transgene 
expression after sub-retinal delivery in wt animals. Additionally, the observed translocation 
of transduced prominin-1::GFP fusion constructs to the IS of wt photoreceptors indicates a 
native-like targeting of our construct. In short-term experiments, I could show that 
prominin-1, virally  delivered to the prominin-1 knock-out retina, is specifically expressed in 
the host photoreceptors and expression could be observed at its native location, i.e. the 
base of the OS. First expression could be observed 2 weeks after injection and ONL 
thickness preservation could be detected 3 weeks after injection on a histological base.
! In contrast to this, long-term studies revealed until now negative effects of this 
treatment. Experimental prominin-1 knock-out animals which were treated with rAAV2/8 
viral vectors expressing wt prominin-1 were analyzed 8 or 10 weeks after using ERG 
measurements and histological sectioning. Histology revealed a thinner ONL and an 
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impaired photoreceptor IS integrity  in treated versus untreated, contralateral retinas. This 
was verified by ERG measurements where treated eyes showed markedly  reduced or no 
signal compared to untreated eyes. This indicates a negative effect of prominin-1 viral 
vector-based delivery  on prominin-1 knock-out host photoreceptors on a long timescale, 
especially  in respect to photoreceptor morphology and survival. This is in contrast to short-
term results and indicates a negative effect, which establishes on a long timescale.
! One reason might be the high-level transgene expression by the viral vector using a 
cytomegalie virus (CMV) promoter. In contrast to the native situation, where prominin-1-
expression is driven by  its own promoter regulating its expression level, in our 
therapeutical approach, prominin-1 might be over-expressed leading to an accumulation at 
the target location as well as neighboring membranes, like the IS, as observed in the long-
term study as well as in prominin-1::GFP fusion construct experiments. This might be 
detrimental to IS structure as well as intra-cellular trafficking. Additionally, photoreceptors 
are remarkably specialized neuronal cells with high protein turnover and energy 
consumption. Therefore, the introduction of multiple copies of high level prominin-1-
expressing CMV promoter constructs might affect photoreceptor cells already on low 
thresholds. Last but not least, there might be a day-night cycle in expression levels of 
native prominin-1 as reported from Xenopus laevis photoreceptors [84]. Since prominin-1 
is closely connected to the formation of new discs, and these are known to be shedded 
and therefore renewed in a light dependent cyclic manner this seems to be highly  probable 
and should be subject of further studies. The usage of the prominin-1 promoter might 
therefore mimic its native expression better than the constantly expressing CMV promoter. 
Future studies will focus on using the native prominin-1 promoter including testing of 
Prominin-1 protein levels per retina. This might result in native Prominin-1 levels at the 
right time in transduced cells of a prominin-1 knock-out retina and a survival of these cells, 
together with functional recovery.
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! The fact, that I could detect a direct correlation between ERG signal quality and 
ONL thickness as well as photoreceptor IS integrity, proves ERG measurements as a 
reliable tool to detect functional changes in ocular gene-therapeutical studies. Additionally I 
was able to detect a direct connection between the quality of injection and the integrity and 
survival rate of host photoreceptor cells. This indicates the importance of minimal invasive 
ocular delivery strategies, especially  according to the treatment of patients with retinal 
degenerative diseases, where diseased photoreceptor cells might be more sensitive to 
surgical procedures, compared to healthy patients‘ photoreceptors.
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5) Summary
Current studies follow a variety of different strategies to overcome permanent and, to date, 
incurable vision loss caused by retinal degenerative diseases. They could be generally 
classified as chemical, biological and technical approaches whereas some of them 
combine features from different disciplines (Fig. 21).
Figure 21: Overview of strategies for the treatment of retinal degenerative diseases.
! Chemical approaches focus mainly on the usage of signaling molecules which have 
neuro-protective or growth-inducing effects and on antibodies for defined receptors to 
manipulate cell behavior. Neuro-protective and sub-cellular regenerative effects have been 
demonstrated for the treatment of retinal degeneration e.g. with the application of ciliary 
neurotrophic factor (CNTF) [85-87], human transferrin [88], curcumin [89], N-acetyl 
serotonin [90] and rare earth nanoparticles [91] mainly to the vitreus body of the eye. For 
the treatment of neovascular age-related macula degeneration (AMD), anti-vascular 
endothelial growth factor (VEGF) antibody therapy has been proven to treat successfully 
one major symptom (neovascularisation) resulting in a decrease in the rate of 
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degeneration [92,93]. A recent elegant approach combines chemistry with photosensitivity 
by applying a photochemical active small molecule “photoswitch“ to the retina of blind mice 
resulting in restored light responsiveness [94].
! While most of the chemical approaches may be beneficial only in early disease 
stages retinal prosthesis approaches represent a technical solution applicable to a 
severely  degenerated retina. The principle of this strategy is the replacement of 
degenerated photoreceptor cells by electronic chip  implants which detect light and 
stimulate the remaining retinal cells via electric signals [95]. These studies are in advanced 
stages and some prostheses are already tested in clinical trials [34,96,97]. Recent 
advances in this field focus on the optimization of these prostheses in respect to resolution 
[98] or independence from external power sources [99].
! Beside chemical and technical approaches, biological approaches represent a 
promising field where protecting, restoring or regenerative therapies might be established 
soon. They could be divided into cell therapies and gene therapies. One gene therapeutic 
field with intensive research focuses on optogenetic approaches [100] following the idea, 
that the remaining neuronal cells in a photoreceptor-depleted, degenerated retina can be 
turned into light-sensing cells by transgenic expression of opsins [101]. Recent work 
demonstrates the restoration of visual responses by introducing microbial channel-
rhodopsins [102,103] or melanopsin [104] in retinal ganglion cells (RGCs) or 
channelrhodopsin in ON bipolar cells [105,106] as well as by introducing archaebacterial 
halorhodopsin in light-insensitive, remaining cones in a severely degenerated RP retina 
[107].
! While optogenetic approaches focus on late-stage diseases, general gene 
therapeutical approaches have to be applied at early stages, when photoreceptors are still 
left. The principle of an ocular gene therapy focusses on hereditary retinal degenerations 
and the fact, that a mutated gene, which leads to retinal degeneration, can be replaced by 
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a vector-delivered wt gene which results in a cure of the disease at it‘s “root“. AAV-vectors 
have been proven to be the most effective and reliable tool for this task, to date [8-10]. 
Functional rescue has been demonstrated in animal models of autosomal dominant 
[79,80], recessive [81] and X-linked retinitis pigmentosa [82] as well as recessive Leber 
congenital amaurosis [75-77] and achromatopsia [78].
! While first gene therapies for retinal inherited diseases are already in clinical trials 
[108], another strategy, the cell therapy approach, is still in its infancy. In one branch of a 
cell therapy, helper cells like mesenchymal stem cells (MSCs) are transplanted to the 
retina or the vitreus body [109]. Their neuroprotective properties are topic of current 
research e.g. in animal models of glaucoma where they elicit this effect by native paracrine 
neurotrophic factor secretion [110] or as genetically modified cells by brain-derived 
neurotrophic factor release [111].
! Researchers following another branch of retinal cell therapy focus on replacing 
degenerated photoreceptor cells by sub-retinal injected wt photoreceptor source cells, 
which integrate in the remaining, or form a new photoreceptor layer. These photoreceptor 
source cells are the topic of current research and controversial discussions. For PPCs, 
isolated from post-natal day 4 retinas, successful transplantation and integration has been 
shown [15,16] but in vitro expansion without losing their PPC  state has not been reported 
until now. Several groups investigated the potential of expandable cells isolated from the 
retina, the so-called “retinal stem cells” [56-59],  pluripotent stem cells, i.e. ESCs [18,24] or 
iPS cells [25,42,60] with different success in outcome. Currently, ESCs elicit the highest 
potential to be a reliable, stable and successful source for PPCs, whereas, because of 
ethical concerns, iPS cells might be the best choice for the future.
! Like optogenetic approaches, photochemical treatments and retinal prostheses, a 
photoreceptor cell replacement therapy implies the advantage, that diseases like RP, with 
common phenotype, but a variety of genes that might be mutated, may be cured at once, 
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here specifically by introducing new, genetically native PPCs. In these cases, a gene 
therapy has to be developed for each gene that is mutated and therefore for each group of 
patients that are affected. Also, gene therapy  requires remaining viable host photoreceptor 
cells, whereas a photoreceptor cell replacement therapy might be applicable in severely 
degenerated retinas. Another advantage of this therapy in contrast to optogenetic 
approaches, photochemical treatments or retinal prostheses is, that an optimal, native 
resolution of the eye with almost one hundred million photoreceptors [2] may only be 
achieved in near future by introducing new photoreceptor cells to a diseased retina. In 
comparison, the current maximal resolution of optogenetic or photochemical therapies is 
limited by  the number of remaining neurons, whereas a stimulation of RGCs with already 
processed optical signals represents a promising strategy to overcome this problem [98]. 
In line with optogenetics and photochemical treatment, retinal prostheses share the 
disadvantage of currently low resolution. Also here, research is made to improve the 
density of electrodes to increase the amount of pixels. Nevertheless, a stable and proven 
retinal cell therapy represents the most promising treatment for high quality vision gain in 
retinal degenerative diseases, to date.
! Summing up, this study shows, that with pre-transplantational sorting, using the 
PPC-specific cell surface marker CD73, a significant enhancement of the integration rate 
of PPCs in wt host retinas can be achieved. Next to this quantitative approach, it is also 
shown that the quality  of transplanted PPCs is comparable to native photoreceptors by 
demonstrating, that an indispensable prerequisite of every  photoreceptor cell, the OS, is 
developed by transplanted PPCs after integration and even when not integrated and sub-
retinal located. Additionally, I could show, that this is not the case when PPCs are 
transplanted to the vitreal side of the retina, suggesting an influence of signaling molecules 
presumably secreted by RPE cells into the sub-retinal space.
70
! Last, but not least, the gene therapeutical part of this work demonstrates, that a 
treatment of prominin-1 mutations-derived retinal degenerative diseases with the use of 
recombinant AAV vectors by delivering native prominin-1 selectively to the patients‘ 
photoreceptor cells might be possible. The divergent results show on one hand a rescue of 
the thickness of the photoreceptor ONL on a short time period, and on the other hand 
long-term data suggests histologically as well as functionally a negative effect on treated 
eyes. This might be due to effects caused by an over-expression of prominin-1 and will be 
investigated in further studies.
! In conclusion, distinct and important investigations were made which contribute 
significant puzzle pieces to new cell- as well as gene therapeutical approaches for the 
treatment of retinal degenerative disorders.
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6) Material and Methods
Ethics Statement
All animal experiments were carried out in strict accordance with European Union and 
German laws (Tierschutzgesetz) and adhered to the ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research. All animal experiments were approved by the 
animal ethics committee of the TU Dresden and the Landesdirektion Dresden (approval 
number: 24D-9168.11-1/2008-33).
Animals
Donor cells were isolated from retinas of PN4 transgenic reporter mice. The first 
transgenic animal used is characterized by the expression of EGFP fused to human 
rhodopsin, which is introduced into the mouse rhodopsin locus (rhoEGFP mice) [33]. This 
reporter fusion protein facilitates the selective labeling and tracking of OS development 
since rhodopsin is specifically  located therein. The second reporter mouse line was 
generated by crossing the rhoEGFP mouse line with the actin-DsRed one, in which DsRed 
expression is driven by an ubiquitous active chicken beta-actin promoter (DsRed, B6.Cg-
Tg(CAG-DsRed*MST)1Nagy/J from The Jackson Laboratory, Maine, USA; [112]). This 
double reporter mouse line allows the tracking of transplanted PPCs simultaneously  to the 
development of their OSs in host retinas. The third reporter mouse line is the Nrl-EGFP 
line [113]. In Nrl-EGFP mice a transgene coding for EGFP driven by the Nrl promoter was 
introduced. Nrl is a transcription factor determining the rod fate and the earliest known 
marker for rod photoreceptors. Donor cells were either transplanted into wild-type mice 
(C57BL/6J; age: 2 – 4 months) or heterozygous P347S mice (age: 4 and 12 weeks, n = 5), 
a model for autosomal-dominant RP [50]. For light-sensitivity studies, PN4, CD73-positive 
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sorted actinDsRed, rhoEGFP double reporter donor cells were transplanted into P347S 
mice (age: 10 weeks, n=4), which were light-adapted (10h in normal ambient light) or dark-
adapted (24h in complete darkness) 4 weeks after transplantation.
Magnetic-activated cell sorting (MACS)
PPCs were enriched from 4-days old reporter mouse retinas using CD73 as a cell surface 
marker and immuno-paramagnetic separation methods as reported [30]. In brief, isolated 
retinas were dissociated, pelleted and dissolved in MACS buffer (Miltenyi Biotec, Bergisch 
Gladbach, Germany). After incubation with rat anti-CD73 antibodies (BD Pharmingen, 
Heidelberg, Germany), cells were washed and incubated with secondary anti-rat 
antibodies coupled with magnetic beads (Miltenyi Biotec), followed by a second washing 
step and filtering through a 30-µm pre-separation filter. Afterwards, magnetic separation 
was performed according to the manufacturer’s protocol (Miltenyi Biotec). The CD73–
positive cell fraction was collected and used for transplantations.
Recombinant adeno-associated virus vector (rAAV) preparation
The mouse prominin-1 gene (GenBank Acc. No. AF026269) was provided by Denis 
Corbeil (Biotec, TU Dresden) as insert in pRC/CMV vector (Invitrogen). Recombinant rAAV 
vectors were created by Prof. Regine Heilbronn and Dr. Stefan Weger (Charité, Berlin). 
Briefly, HEK-293 cells were infected with packaging constructs containing the transgene 
(prominin-1 or GFP or prominin-1::GFP) together with helper constructs containing the 
respective AAV Rep and Cap gene for serotypes 2/5 and 2/8 as well as adenoviral helper 
genes. The transgene transcripts are driven by  an ubiquitously  active cytomegalie virus 
(CMV) promotor (see also appendix Figs. S2-S4).
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Immunohisto/cytochemistry
Whole mouse eyes were extracted from animals and processed as described in Eberle et 
al., 2011 [30]. Briefly, after fixation in 4% paraformaldehyde (PFA), the retina was 
dissected out and sectioned into 30-µm thick slices using a vibrating microtome (model 
1200; Leica, Wetzlar, Germany). To visualize cell nuclei, samples were stained with 4’,6-
diamidino-2-phenylindole (DAPI; 1:10,000; Sigma-Aldrich, Munich, Germany). For 
immuno-staining fixed samples were blocked (30min) in PBS containing 5% goat serum 
(Sigma), 1% bovine serum albumin (BSA; Sigma), and 0.3% Triton X-100 (TU-Dresden 
pharmacy, Dresden, Germany), and incubated (4℃ o/n) with the following primary 
antibodies: mouse anti-rhodopsin (rho4D2; 1:100; kind gift of R. Molday, University of 
British Columbia, Vancouver, BC, Canada or anti-Ret-P1, Sigma-Aldrich, Munich, 
Germany), rabbit anti-recoverin (1:3000; Millipore, Schwalbach, Germany) or rabbit anti-
transducin (anti-Gα t1, Santa Cruz Biotechnology, Santa Cruz, USA) antibodies. Primary 
antibodies were visualized by incubation (2h) with Cy2, Cy3 or Cy5-conjugated goat anti-
mouse, anti-rabbit, or anti-rat secondary antibodies (Jackson Immunoresearch, West 
Grove, USA), respectively. Retinal sections were mounted on glass slides with 
AquaPolymount (Polysciences, Inc., Warrington, PA, US) for image acquisition.
Transplantation / Transduction
For transplantation of cell suspensions into the sub-retinal or vitreal space, adult (i.e. 2 – 4 
months old) wild-type (C57BL/6J) or heterozygous P347S (4 – 12 weeks old) mice, and for 
injection of viral vector suspension in post-natal day  15 wild-type (C57BL/6J) or Prominin-1 
knock-out animals (AC133-/-), mice were anesthetized by an intra-peritoneal injection of 
medetomidine hydrochloride (Dormitor®, Pfizer, Berlin, Germany; 0.01mg/10g body 
weight) and ketamine (Ratiopharm, Ulm, Germany; 0.75mg/10g body weight) and fixed in 
a head holder. Pupils were dilated by   applying a drop  of 1% tropicamid (Mydrum®, Dr. 
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Mann Pharma GmbH, Berlin, Germany) and 2.5% phenylephrine (TU-Dresden pharmacy). 
A Hamilton syringe with a blunt 34-gauge needle was inserted tangentially through the 
conjunctiva and sclera and placed under visual control into the sub-retinal space, i.e. 
between the retina and RPE producing a bullous retinal detachment, or into the vitreal 
space, i.e. in front of the ganglion cell layer. 1 µl of cell suspension containing 
approximately  400,000 cells or 1µl of viral vector suspension containing approximately  2-8 
x 1011 GP/ml was injected per eye. The viral vectors were always applied sub-retinal while 
cell suspensions were applied sub-retinal and / or vitreal, dependent on the type of 
experiment. For recovery, experimental animals received an injection of atipamozole 
hydrochloride (Antisedan®, Pfizer, 0.1mg/10g body weight) for reversal of medetomidine.
Quantification of integrated photoreceptors
Three weeks after transplantation experimental animals were sacrificed and the eyes were 
removed and fixed in 4% PFA in PBS for 12h. Retinae were dissected out and embedded 
in 4% agarose to produce 30µm thick serial sections using a vibrating microtome (Leica 
1200, Leica, Germany). Beside morphological criteria like a cell body  located in the ONL 
and the generation of spherule synapses and/or inner segments integrated donor 
photoreceptors were identified by their red (DsRed in the cell body) and green (EGFP in 
the outer segments) fluorescence. For quantification seven retinae that received unsorted 
cell fractions, six retinae that received CD73-negative fractions, and seven retinae that 
received CD73-positive fractions were analyzed. The number of integrated donor cells per 
retina was calculated following quantification of every fourth serial section with a total of 18 
sections per experimental retina using a Z1-Imager fluorescence microscope with 
ApoTome (Zeiss).
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Electro-retinogram (ERG) measurements
ERG measurements were done with the Roland Consult Ganzfeld ERG Q450 system 
(Roland Consult, Brandenburg an der Havel, Germany) with animal table A1 adapter for 
mouse ERG investigations. After dark adaption for at least 12h, animals were kept for the 
whole ERG procedure in a dark room with red light. They were anesthetized as described 
above (see Transplantation / Transduction), placed at the table and connected to the 
respective electrodes. After checking the correct impedance, a scotopic Ganzfeld ERG 
series was launched with stimulus intensities ranging from 0.0003 - 10 cd × s / m2. Finally, 
animals received an injection of atipamozole hydrochloride as described above (see 
Transplantation / Transduction) for reversal of anesthesia.
Correlative light and electron microscopy (CLEM)
Retina pieces were fixed with 4% PFA in 0.1 M phosphate buffer (PB, pH 7.4) overnight at 
4°C. Fixed samples were processed for PLT-embedding in K4M as described [45,46]. In 
brief, samples were dehydrated in a graded series of ethanol at progressively lower 
temperatures, infiltrated in mixtures of ethanol/K4M at -35°C and embedded in resin. 
Polymerization occurred via UV-irradiation at -35°C. Ultra-thin sections were used for 
immunofluorescence and/or immuno-EM [45-47,114]. Sections were blocked with 1% BSA 
in PBS, incubated with rabbit anti-GFP (TP 401 from Torrey Pines or ab 290 from Abcam) 
followed by either Alexa488 (or Alexa555) conjugated secondary antibodies or by  protein 
A 10-nm gold, and finally  counterstained with DAPI (1 µg / ml). For CLEM of the very same 
section, ultra-thin sections were mounted on nickel finder grids (200 mesh, EMS, # G 
200F1-Ni) and stained with anti-GFP antibody and protein A gold. After post-fixation with 
1% glutaraldehyde / PBS, the sections were incubated with goat anti-rabbit Alexa488 and 
counterstained with DAPI. Labeled EM-grids were mounted between two coverslips in 
50% glycerin/water [114] and analyzed at the fluorescence microscope, then de-mounted, 
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washed several times in water and stained with aqueous uranyl acetate before EM 
inspection.
Image acquisition and data analysis
Light microscopical images were taken using a Z1-Imager fluorescence microscope with 
Apotome and AxioCam Mrm camera (Zeiss, Germany). Before EM image acquisition, the 
fluorescence of CLEM samples was imaged using a Keyence BZ 8000 (Keyence, Neu-
Isenburg, Germany). EM sections were analyzed using a Philips Morgagni 268 (FEI; 
Philips, Amsterdam, Netherlands) at 80kV and images were taken with the MegaView III 
digital camera (Olympus, Hamburg, Germany). Images were analyzed and prepared for 
publication using ImageJ, AxioVision (Zeiss), GNU Image Manipulation Program (Gimp) 
and iWork Keynote (Apple). Statistical data were analyzed using Microsoft Office Excel 
(Microsoft), or iWork Numbers (Apple) software. Results are presented as ±  SEM 
(standard error of the mean) from at least three independent experiments. Significance 
was calculated by unpaired, 2-tailed, student’s T-test and presented in figures by *p<0.05, 
**p<0.01, ***p<0.001.
77
7) Bibliography
1. Darwin C On the Origin of Species by Means of Natural Selection, Or, The Preservation 
of Favored Races in the Struggle for Life: Project Gutenberg. 242p. p.
2. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE (1990) Human photoreceptor 
topography. J Comp Neurol 292: 497-523.
3. Brown PK, Wald G (1963) Visual Pigments in Human and Monkey Retinas. Nature 200: 
37-43.
4. Carter-Dawson LD, LaVail MM (1979) Rods and cones in the mouse retina. I. Structural 
analysis using light and electron microscopy. J Comp Neurol 188: 245-262.
5. Berson DM (2007) Phototransduction in ganglion-cell photoreceptors. Pflugers Arch 
454: 849-855.
6. Zhang DQ, Wong KY, Sollars PJ, Berson DM, Pickard GE, et al. (2008) Intraretinal 
signaling by ganglion cell photoreceptors to dopaminergic amacrine neurons. Proc 
Natl Acad Sci U S A 105: 14181-14186.
7. Hamel C (2006) Retinitis pigmentosa. Orphanet journal of rare diseases 1: 40.
8. Buch PK, Bainbridge JW, Ali RR (2008) AAV-mediated gene therapy for retinal 
disorders: from mouse to man. Gene Ther 15: 849-857.
9. Alexander JJ, Hauswirth WW (2008) Adeno-associated viral vectors and the retina. Adv 
Exp Med Biol 613: 121-128.
10. Surace EM, Auricchio A (2008) Versatility of AAV vectors for retinal gene transfer. 
Vision Res 48: 353-359.
11. Gouras P, Du J, Kjeldbye H, Kwun R, Lopez R, et al. (1991) Transplanted 
photoreceptors identified in dystrophic mouse retina by a transgenic reporter gene. 
Invest Ophthalmol Vis Sci 32: 3167-3174.
12. Gouras P, Du J, Kjeldbye H, Yamamoto S, Zack DJ (1992) Reconstruction of 
degenerate rd mouse retina by transplantation of transgenic photoreceptors. Invest 
Ophthalmol Vis Sci 33: 2579-2586.
13. Gouras P, Du J, Kjeldbye H, Yamamoto S, Zack DJ (1994) Long-term photoreceptor 
transplants in dystrophic and normal mouse retina. Invest Ophthalmol Vis Sci 35: 
3145-3153.
14. Kwan AS, Wang S, Lund RD (1999) Photoreceptor layer reconstruction in a rodent 
model of retinal degeneration. Experimental neurology 159: 21-33.
78
15. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, et al. (2006) Retinal 
repair by transplantation of photoreceptor precursors. Nature 444: 203-207.
16. Bartsch U, Oriyakhel W, Kenna PF, Linke S, Richard G, et al. (2008) Retinal cells 
integrate into the outer nuclear layer and differentiate into mature photoreceptors 
after subretinal transplantation into adult mice. Exp Eye Res 86: 691-700.
17. Lakowski J, Baron M, Bainbridge J, Barber AC, Pearson RA, et al. (2010) Cone and 
rod photoreceptor transplantation in models of the childhood retinopathy Leber 
congenital amaurosis using flow-sorted Crx-positive donor cells. Hum Mol Genet 
19: 4545-4559.
18. Lamba DA, Gust J, Reh TA (2009) Transplantation of human embryonic stem cell-
derived photoreceptors restores some visual function in Crx-deficient mice. Cell 
Stem Cell 4: 73-79.
19. Pearson RA, Barber AC, Rizzi M, Hippert C, Xue T, et al. (2012) Restoration of vision 
after transplantation of photoreceptors. Nature.
20. West EL, Pearson RA, Tschernutter M, Sowden JC, MacLaren RE, et al. (2008) 
Pharmacological disruption of the outer limiting membrane leads to increased 
retinal integration of transplanted photoreceptor precursors. Exp Eye Res 86: 
601-611.
21. Pearson RA, Barber AC, West EL, MacLaren RE, Duran Y, et al. (2010) Targeted 
disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases 
integration of transplanted photoreceptor precursors into the adult wild-type and 
degenerating retina. Cell Transplant 19: 487-503.
22. West EL, Pearson RA, Barker SE, Luhmann UF, Maclaren RE, et al. (2010) Long-term 
survival of photoreceptors transplanted into the adult murine neural retina requires 
immune modulation. Stem Cells 28: 1997-2007.
23. Yao J, Feathers KL, Khanna H, Thompson D, Tsilfidis C, et al. (2011) XIAP therapy 
increases survival of transplanted rod precursors in a degenerating host retina. 
Investigative ophthalmology & visual science 52: 1567-1572.
24. Lamba DA, Karl MO, Ware CB, Reh TA (2006) Efficient generation of retinal progenitor 
cells from human embryonic stem cells. Proceedings of the National Academy of 
Sciences of the United States of America 103: 12769-12774.
25. Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, et al. (2010) Generation, 
purification and transplantation of photoreceptors derived from human induced 
pluripotent stem cells. PLoS One 5: e8763.
79
26. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, et al. (2008) Toward the 
generation of rod and cone photoreceptors from mouse, monkey and human 
embryonic stem cells. Nature biotechnology 26: 215-224.
27. Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, et al. (2009) Modeling 
early retinal development with human embryonic and induced pluripotent stem cells. 
Proceedings of the National Academy of Sciences of the United States of America 
106: 16698-16703.
28. Koso H, Minami C, Tabata Y, Inoue M, Sasaki E, et al. (2009) CD73, a novel cell 
surface antigen that characterizes retinal photoreceptor precursor cells. 
Investigative ophthalmology & visual science 50: 5411-5418.
29. Lakowski J, Han YT, Pearson RA, Gonzalez-Cordero A, West EL, et al. (2011) 
Effective transplantation of photoreceptor precursor cells selected via cell surface 
antigen expression. Stem Cells 29: 1391-1404.
30. Eberle D, Schubert S, Postel K, Corbeil D, Ader M (2011) Increased integration of 
transplanted CD73-positive photoreceptor precursors into adult mouse retina. 
Investigative ophthalmology & visual science 52: 6462-6471.
31. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene 
expression and hybridization array data repository. Nucleic acids research 30: 
207-210.
32. Akimoto M, Cheng H, Zhu D, Brzezinski JA, Khanna R, et al. (2006) Targeting of GFP 
to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted 
photoreceptors. Proc Natl Acad Sci U S A 103: 3890-3895.
33. Chan F, Bradley A, Wensel TG, Wilson JH (2004) Knock-in human rhodopsin-GFP 
fusions as mouse models for human disease and targets for gene therapy. Proc 
Natl Acad Sci U S A 101: 9109-9114.
34. Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruckmann A, et al. (2011) 
Subretinal electronic chips allow blind patients to read letters and combine them to 
words. Proceedings Biological sciences / The Royal Society 278: 1489-1497.
35. Thomson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, et al. (1990) Production 
and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-
anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73). Tissue 
antigens 35: 9-19.
36. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5'-
nucleotidase (CD73). Purinergic signalling 2: 351-360.
80
37. Singhal S, Lawrence JM, Bhatia B, Ellis JS, Kwan AS, et al. (2008) Chondroitin sulfate 
proteoglycans and microglia prevent migration and integration of grafted Muller 
stem cells into degenerating retina. Stem Cells 26: 1074-1082.
38. Suzuki T, Mandai M, Akimoto M, Yoshimura N, Takahashi M (2006) The simultaneous 
treatment of MMP-2 stimulants in retinal transplantation enhances grafted cell 
migration into the host retina. Stem Cells 24: 2406-2411.
39. Suzuki T, Akimoto M, Imai H, Ueda Y, Mandai M, et al. (2007) Chondroitinase ABC 
treatment enhances synaptogenesis between transplant and host neurons in model 
of retinal degeneration. Cell transplantation 16: 493-503.
40. Gust J, Reh TA (2011) Adult donor rod photoreceptors integrate into the mature mouse 
retina. Investigative ophthalmology & visual science 52: 5266-5272.
41. Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, et al. (2009) Engineering retinal 
progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and 
subretinal transplantation. Biomaterials 30: 3405-3414.
42. Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, et al. (2011) Transplantation of adult 
mouse iPS cell-derived photoreceptor precursors restores retinal structure and 
function in degenerative mice. PLoS One 6: e18992.
43. Gouras P, Du J, Gelanze M, Kwun R, Kjeldbye H, et al. (1991) Transplantation of 
photoreceptors labeled with tritiated thymidine into RCS rats. Invest Ophthalmol Vis 
Sci 32: 1704-1707.
44. Gouras P, Du J, Gelanze M, Lopez R, Kwun R, et al. (1991) Survival and synapse 
formation of transplanted rat rods. J Neural Transplant Plast 2: 91-100.
45. Schwarz H, and Humbel, B. M. (2009) Correlative light and electron microscopy. In: A. 
Cavalier DS, B. M. Humbel, eds., editor. Hand Book of Cryo-Preparation Methods 
for Electron Microscopy: CRC Press, Boca Raton. pp. pp. 537-565.
46. Schwarz H, Humbel BM (2007) Correlative light and electron microscopy using 
immunolabeled resin sections. Methods Mol Biol 369: 229-256.
47. Fabig G, Kretschmar S, Weiche S, Eberle D, Ader M, et al. (2012) Labeling of ultrathin 
resin sections for correlative light and electron microscopy. Methods in cell biology 
111: 75-93.
48. Barber AC, Hippert C, Sowden JC, Ali RR, Pearson RA (2011) Retinal Repair In The 
Degenerating Retina: Assessing Photoreceptor Transplantation In Models Of 
Retinal Disease. ARVO Meeting Abstracts 52: 4019.
81
49. Hippert C, Barber AC, Georgiadis A, Bainbridge JW, Smith AJ, et al. (2012) Modulation 
Of Gliosis Using shGFAP Or/and shvimentin To Determine Its Role In Photoreceptor 
Transplantation Efficiency. ARVO Meeting Abstracts 53: 2010.
50. Li T, Snyder WK, Olsson JE, Dryja TP (1996) Transgenic mice carrying the dominant 
rhodopsin mutation P347S: evidence for defective vectorial transport of rhodopsin 
to the outer segments. Proc Natl Acad Sci U S A 93: 14176-14181.
51. Gaur VP, Liu Y, Turner JE (1992) RPE conditioned medium stimulates photoreceptor 
cell survival, neurite outgrowth and differentiation in vitro. Experimental eye 
research 54: 645-659.
52. Raymond SM, Jackson IJ (1995) The retinal pigmented epithelium is required for 
development and maintenance of the mouse neural retina. Current biology 5: 
1286-1295.
53. Sheedlo HJ, Nelson TH, Lin N, Rogers TA, Roque RS, et al. (1998) RPE secreted 
proteins and antibody influence photoreceptor cell survival and maturation. Brain 
research Developmental brain research 107: 57-69.
54. Stiemke MM, Landers RA, al-Ubaidi MR, Rayborn ME, Hollyfield JG (1994) 
Photoreceptor outer segment development in Xenopus laevis: influence of the 
pigment epithelium. Developmental biology 162: 169-180.
55. Lin N, Fan W, Sheedlo HJ, Aschenbrenner JE, Turner JE (1996) Photoreceptor repair 
in response to RPE transplants in RCS rats: outer segment regeneration. Current 
eye research 15: 1069-1077.
56. Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, et al. (2000) Retinal stem 
cells in the adult mammalian eye. Science 287: 2032-2036.
57. Klassen HJ, Ng TF, Kurimoto Y, Kirov I, Shatos M, et al. (2004) Multipotent retinal 
progenitors express developmental markers, differentiate into retinal neurons, and 
preserve light-mediated behavior. Investigative ophthalmology & visual science 45: 
4167-4173.
58. Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, et al. (2004) Facile 
isolation and the characterization of human retinal stem cells. Proceedings of the 
National Academy of Sciences of the United States of America 101: 15772-15777.
59. Merhi-Soussi F, Angenieux B, Canola K, Kostic C, Tekaya M, et al. (2006) High yield of 
cells committed to the photoreceptor fate from expanded mouse retinal stem cells. 
Stem Cells 24: 2060-2070.
60. Comyn O, Lee E, MacLaren RE (2010) Induced pluripotent stem cell therapies for 
retinal disease. Current opinion in neurology 23: 4-9.
82
61. Zacchigna S, Oh H, Wilsch-Brauninger M, Missol-Kolka E, Jaszai J, et al. (2009) Loss 
of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis 
and photoreceptor degeneration. J Neurosci 29: 2297-2308.
62. Permanyer J, Navarro R, Friedman J, Pomares E, Castro-Navarro J, et al. (2010) 
Autosomal recessive retinitis pigmentosa with early macular affectation caused by 
premature truncation in PROM1. Invest Ophthalmol Vis Sci 51: 2656-2663.
63. Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC, et al. (2000) A frameshift 
mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol 
Genet 9: 27-34.
64. Zhang Q, Zulfiqar F, Xiao X, Riazuddin SA, Ahmad Z, et al. (2007) Severe retinitis 
pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 
gene. Hum Genet 122: 293-299.
65. Pras E, Abu A, Rotenstreich Y, Avni I, Reish O, et al. (2009) Cone-rod dystrophy and a 
frameshift mutation in the PROM1 gene. Mol Vis 15: 1709-1716.
66. Littink KW, Koenekoop RK, van den Born LI, Collin RW, Moruz L, et al. (2010) 
Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and 
clinical characterizations. Invest Ophthalmol Vis Sci 51: 5943-5951.
67. Kniazeva M, Chiang MF, Morgan B, Anduze AL, Zack DJ, et al. (1999) A new locus for 
autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum 
Genet 64: 1394-1399.
68. Michaelides M, Johnson S, Poulson A, Bradshaw K, Bellmann C, et al. (2003) An 
autosomal dominant bull's-eye macular dystrophy (MCDR2) that maps to the short 
arm of chromosome 4. Invest Ophthalmol Vis Sci 44: 1657-1662.
69. Yang Z, Chen Y, Lillo C, Chien J, Yu Z, et al. (2008) Mutant prominin 1 found in 
patients with macular degeneration disrupts photoreceptor disk morphogenesis in 
mice. J Clin Invest 118: 2908-2916.
70. Michaelides M, Gaillard MC, Escher P, Tiab L, Bedell M, et al. (2010) The PROM1 
mutation p.R373C causes an autosomal dominant bull's eye maculopathy 
associated with rod, rod-cone, and macular dystrophy. Invest Ophthalmol Vis Sci 
51: 4771-4780.
71. Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, et al. (2007) Novel 
adeno-associated virus serotypes efficiently transduce murine photoreceptors. J 
Virol 81: 11372-11380.
83
72. Pang JJ, Lauramore A, Deng WT, Li Q, Doyle TJ, et al. (2008) Comparative analysis of 
in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of 
serotype and site of administration. Vision Res 48: 377-385.
73. Natkunarajah M, Trittibach P, McIntosh J, Duran Y, Barker SE, et al. (2008) 
Assessment of ocular transduction using single-stranded and self-complementary 
recombinant adeno-associated virus serotype 2/8. Gene Ther 15: 463-467.
74. Wang J, Faust SM, Rabinowitz JE (2011) The next step in gene delivery: molecular 
engineering of adeno-associated virus serotypes. J Mol Cell Cardiol 50: 793-802.
75. Boye SE, Boye SL, Pang J, Ryals R, Everhart D, et al. (2010) Functional and 
behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) 
knockout mouse. PLoS One 5: e11306.
76. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, et al. (2001) Gene therapy 
restores vision in a canine model of childhood blindness. Nature genetics 28: 92-95.
77. Ku CA, Chiodo VA, Boye SL, Goldberg AF, Li T, et al. (2011) Gene therapy using self-
complementary Y733F capsid mutant AAV2/8 restores vision in a model of early 
onset Leber congenital amaurosis. Human molecular genetics 20: 4569-4581.
78. Pang JJ, Deng WT, Dai X, Lei B, Everhart D, et al. (2012) AAV-mediated cone rescue 
in a naturally occurring mouse model of CNGA3-achromatopsia. PLoS One 7: 
e35250.
79. Mao H, Gorbatyuk MS, Hauswirth WW, Lewin AS (2012) Gene delivery of wild-type 
rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa 
mouse model. Advances in experimental medicine and biology 723: 199-205.
80. Gorbatyuk MS, Gorbatyuk OS, LaVail MM, Lin JH, Hauswirth WW, et al. (2012) 
Functional rescue of P23H rhodopsin photoreceptors by gene delivery. Advances in 
experimental medicine and biology 723: 191-197.
81. Pang JJ, Dai X, Boye SE, Barone I, Boye SL, et al. (2011) Long-term retinal function 
and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model 
of recessive retinitis pigmentosa. Mol Ther 19: 234-242.
82. Beltran WA, Cideciyan AV, Lewin AS, Iwabe S, Khanna H, et al. (2012) Gene therapy 
rescues photoreceptor blindness in dogs and paves the way for treating human X-
linked retinitis pigmentosa. Proceedings of the National Academy of Sciences of the 
United States of America 109: 2132-2137.
83. Corbeil D, Roper K, Hannah MJ, Hellwig A, Huttner WB (1999) Selective localization of 
the polytopic membrane protein prominin in microvilli of epithelial cells - a 
84
combination of apical sorting and retention in plasma membrane protrusions. J Cell 
Sci 112 ( Pt 7): 1023-1033.
84. Han Z, Anderson DW, Papermaster DS (2012) Prominin-1 localizes to the open rims of 
outer segment lamellae in Xenopus laevis rod and cone photoreceptors. Invest 
Ophthalmol Vis Sci 53: 361-373.
85. Wen R, Tao W, Li Y, Sieving PA (2012) CNTF and retina. Prog Retin Eye Res 31: 
136-151.
86. Wen R, Tao W, Luo L, Huang D, Kauper K, et al. (2012) Regeneration of cone outer 
segments induced by CNTF. Adv Exp Med Biol 723: 93-99.
87. Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, et al. (2011) Longitudinal 
study of cone photoreceptors during retinal degeneration and in response to ciliary 
neurotrophic factor treatment. Invest Ophthalmol Vis Sci 52: 2219-2226.
88. Picard E, Jonet L, Sergeant C, Vesvres MH, Behar-Cohen F, et al. (2010) 
Overexpressed or intraperitoneally injected human transferrin prevents 
photoreceptor degeneration in rd10 mice. Mol Vis 16: 2612-2625.
89. Vasireddy V, Chavali VR, Joseph VT, Kadam R, Lin JH, et al. (2011) Rescue of 
photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin 
mutation. PLoS One 6: e21193.
90. Shen J, Ghai K, Sompol P, Liu X, Cao X, et al. (2012) N-acetyl serotonin derivatives as 
potent neuroprotectants for retinas. Proc Natl Acad Sci U S A 109: 3540-3545.
91. Chen J, Patil S, Seal S, McGinnis JF (2006) Rare earth nanoparticles prevent retinal 
degeneration induced by intracellular peroxides. Nat Nanotechnol 1: 142-150.
92. Kovach JL, Schwartz SG, Flynn HW, Jr., Scott IU (2012) Anti-VEGF Treatment 
Strategies for Wet AMD. J Ophthalmol 2012: 786870.
93. Lally DR, Gerstenblith AT, Regillo CD (2012) Preferred therapies for neovascular age-
related macular degeneration. Curr Opin Ophthalmol 23: 182-188.
94. Polosukhina A, Litt J, Tochitsky I, Nemargut J, Sychev Y, et al. (2012) Photochemical 
restoration of visual responses in blind mice. Neuron 75: 271-282.
95. Fernandes RA, Diniz B, Ribeiro R, Humayun M (2012) Artificial vision through neuronal 
stimulation. Neurosci Lett 519: 122-128.
96. Wilke R, Gabel VP, Sachs H, Bartz Schmidt KU, Gekeler F, et al. (2011) Spatial 
resolution and perception of patterns mediated by a subretinal 16-electrode array in 
patients blinded by hereditary retinal dystrophies. Invest Ophthalmol Vis Sci 52: 
5995-6003.
85
97. Stingl K, Bartz-Schmidt KU, Besch D, Gekeler F, Greppmaier U, et al. (2012) [What 
can blind patients see in daily life with the subretinal Alpha IMS implant? Current 
overview from the clinical trial in Tubingen]. Ophthalmologe 109: 136-141.
98. Nirenberg S, Pandarinath C (2012) Retinal prosthetic strategy with the capacity to 
restore normal vision. Proc Natl Acad Sci U S A.
99. Wang L, Mathieson K, Kamins TI, Loudin JD, Galambos L, et al. (2012) Photovoltaic 
retinal prosthesis: implant fabrication and performance. J Neural Eng 9: 046014.
100. Rein ML, Deussing JM (2012) The optogenetic (r)evolution. Mol Genet Genomics 
287: 95-109.
101. Busskamp V, Picaud S, Sahel JA, Roska B (2012) Optogenetic therapy for retinitis 
pigmentosa. Gene Ther 19: 169-175.
102. Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, et al. (2006) Ectopic expression of a 
microbial-type rhodopsin restores visual responses in mice with photoreceptor 
degeneration. Neuron 50: 23-33.
103. Tomita H, Sugano E, Isago H, Hiroi T, Wang Z, et al. (2010) Channelrhodopsin-2 
gene transduced into retinal ganglion cells restores functional vision in genetically 
blind rats. Exp Eye Res 90: 429-436.
104. Lin B, Koizumi A, Tanaka N, Panda S, Masland RH (2008) Restoration of visual 
function in retinal degeneration mice by ectopic expression of melanopsin. Proc Natl 
Acad Sci U S A 105: 16009-16014.
105. Lagali PS, Balya D, Awatramani GB, Munch TA, Kim DS, et al. (2008) Light-activated 
channels targeted to ON bipolar cells restore visual function in retinal degeneration. 
Nat Neurosci 11: 667-675.
106. Doroudchi MM, Greenberg KP, Liu J, Silka KA, Boyden ES, et al. (2011) Virally 
delivered channelrhodopsin-2 safely and effectively restores visual function in 
multiple mouse models of blindness. Mol Ther 19: 1220-1229.
107. Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, et al. (2010) Genetic 
reactivation of cone photoreceptors restores visual responses in retinitis 
pigmentosa. Science 329: 413-417.
108. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, et al. (2012) 
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety 
and efficacy in 15 children and adults followed up to 3 years. Archives of 
ophthalmology 130: 9-24.
109. Joe AW, Gregory-Evans K (2010) Mesenchymal stem cells and potential applications 
in treating ocular disease. Curr Eye Res 35: 941-952.
86
110. Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, et al. (2010) Neuroprotective 
effects of intravitreal mesenchymal stem cell transplantation in experimental 
glaucoma. Invest Ophthalmol Vis Sci 51: 2051-2059.
111. Harper MM, Grozdanic SD, Blits B, Kuehn MH, Zamzow D, et al. (2011) 
Transplantation of BDNF-secreting mesenchymal stem cells provides 
neuroprotection in chronically hypertensive rat eyes. Invest Ophthalmol Vis Sci 52: 
4506-4515.
112. Baird GS, Zacharias DA, Tsien RY (2000) Biochemistry, mutagenesis, and 
oligomerization of DsRed, a red fluorescent protein from coral. Proceedings of the 
National Academy of Sciences of the United States of America 97: 11984-11989.
113. Yamaguchi M, Saito H, Suzuki M, Mori K (2000) Visualization of neurogenesis in the 
central nervous system using nestin promoter-GFP transgenic mice. Neuroreport 
11: 1991-1996.
114. Vicidomini G, Gagliani MC, Canfora M, Cortese K, Frosi F, et al. (2008) High data 
output and automated 3D correlative light-electron microscopy method. Traffic 9: 
1828-1838.
87
8) Acknowledgements
I like to thank John Wilson, PhD for rhoEGFP mice, Anand Swaroop, PhD for Nrl-EGFP 
mice, Profs. Thaddeus P. Dryja, Jane Farrar, and Peter Humphries for P347S mice, 
Jochen Haas, Susanne Kretschmar and Anne-Marie Marzesco for technical support, 
Carmen Friebel and Sindy Böhme for animal husbandry, Drs. Denis Corbeil, Annette 
Rünker and Mike Karl for helpful discussions and critically reading the manuscripts and my 
thesis advisory committee members Andrew C. Oates, PhD and Prof. Dr. Elly M. Tanaka 
for perfect supervision and fruitful discussions.
! Especially, I like to thank Drs. Marius Ader, Thomas Kurth, Sandra Schubert, Stefan 
Weger and Prof. Regine Heilbronn, as well as Kai Postel, Tiago Santos-Ferreira and 
Madalena Carido since without their engagement and dedication this work would not have 
been possible.
! Last, but not least, I like to thank my significant other, all members of my family, her 
family and our closest friends for being there whenever needed, for emotional backup and 
for the “wunderbar“ and happy times I had with them.
88
9) Appendix
Figure S1: Other retinal cell types which might be transduced in low numbers. 
Depicted here is a Müller glia cell which was transduced after sub-retinal delivery of 
rAAV2/5-CMV-prominin-1::GFP, expressing prominin-1::GFP transgene (green). Nuclear 
DAPI staining is shown in white.
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Figure S2: Vector map pTR-UF5. Monomeric vector expressing GFP used for packaging 
with 2/5 or 2/8 capsid.
Figure S3: Vector map pTR-CMV-Prominin. Monomeric vector expressing mouse 
prominin-1 used for packaging with 2/8 capsid.
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Figure S4: Vector map pTR-CMV-Prominin-GFP. Monomeric vector expressing 
prominin-1::GFP fusion protein used for packaging with 2/5 capsid.
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